RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | overnutrition |
|
Accession: | DOID:654
|
browse the term
|
Definition: | A nutrition disease that is characterized by an excess of a nutritional element, such as a vitamin, mineral, carbohydrate, protein, fat, or general energy content. (DO) |
Synonyms: | exact_synonym: | hypernutrition |
| primary_id: | MESH:D044343 |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
IEP |
mRNA:decreased expression:renal artery (rat) |
RGD |
PMID:28958692 |
RGD:13450942 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
|
G |
Cd163 |
CD163 molecule |
exacerbates |
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:31027316 |
RGD:127345132 |
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cyp2r1 |
cytochrome P450, family 2, subfamily r, polypeptide 1 |
|
ISO |
DNA:SNP:CDS: rs12794714 (human) |
RGD |
PMID:34906413 |
RGD:401900724 |
NCBI chr 1:168,749,302...168,798,079
Ensembl chr 1:168,751,038...168,797,759
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15199296 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
|
G |
Ctf1 |
cardiotrophin 1 |
|
ISS |
|
MouseDO |
|
|
NCBI chr 1:182,328,035...182,336,346
Ensembl chr 1:182,328,090...182,333,335
|
|
G |
Gucy2c |
guanylate cyclase 2C |
|
ISS |
|
MouseDO |
|
|
NCBI chr 4:169,568,505...169,649,092
Ensembl chr 4:169,568,529...169,649,092
|
|
G |
Lep |
leptin |
|
ISS |
|
MouseDO |
|
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Neil1 |
nei-like DNA glycosylase 1 |
|
ISS |
|
MouseDO |
|
|
NCBI chr 8:57,550,142...57,556,884
Ensembl chr 8:57,550,147...57,556,258
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15309680 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISS |
|
MouseDO |
|
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
|
IEP |
mRNA:increased expression:gastrocnemius muscle (rat) |
RGD |
PMID:23320128 |
RGD:7241841 |
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Prkci |
protein kinase C, iota |
|
ISS |
|
MouseDO |
|
|
NCBI chr 2:112,321,919...112,382,305
Ensembl chr 2:112,321,929...112,382,352
|
|
G |
Sirt3 |
sirtuin 3 |
|
ISS |
|
MouseDO |
|
|
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
|
|
G |
Slc2a9 |
solute carrier family 2 member 9 |
|
ISS |
|
MouseDO |
|
|
NCBI chr14:72,328,334...72,461,981
Ensembl chr14:72,328,320...72,461,981
|
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
|
IDA |
protein:increased oxidation:cardiac muscle cell |
RGD |
PMID:23997093 |
RGD:13782087 |
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:27131981 |
RGD:13792503 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:27131981 |
RGD:13792503 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
IEP |
|
RGD |
PMID:27131981 |
RGD:13792503 |
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fas |
Fas cell surface death receptor |
|
IEP |
|
RGD |
PMID:30172001 |
RGD:13792561 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Lep |
leptin |
|
ISS |
OMIM:605552 |
MouseDO |
|
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lpl |
lipoprotein lipase |
treatment |
IDA |
|
RGD |
PMID:26996629 |
RGD:13794382 |
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
|
ISO |
ClinVar Annotator: match by term: Abdominal obesity-metabolic syndrome 1 |
ClinVar |
PMID:8533758 PMID:9671739 PMID:16199547 PMID:16721486 PMID:21394827 PMID:25741868 PMID:27578136 PMID:28492532 PMID:30522860 PMID:33258201 More...
|
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Tlr2 |
toll-like receptor 2 |
susceptibility |
ISO |
|
RGD |
PMID:19841034 |
RGD:15090861 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
ISS |
OMIM:605552 |
MouseDO |
|
|
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
|
|
|
G |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
|
ISO |
ClinVar Annotator: match by term: Abdominal obesity-metabolic syndrome 3 |
ClinVar |
PMID:25741868 PMID:29696776 PMID:33644933 |
|
NCBI chr 5:145,228,228...145,294,170
Ensembl chr 5:145,228,227...145,294,145
|
|
G |
Dyrk1b |
dual specificity tyrosine phosphorylation regulated kinase 1B |
|
ISO |
ClinVar Annotator: match by term: Abdominal obesity-metabolic syndrome 3 | ClinVar Annotator: match by term: DYRK1B-related condition |
OMIM ClinVar |
PMID:9536098 PMID:17576681 PMID:24827035 PMID:25741868 PMID:28492532 PMID:32041611 More...
|
|
NCBI chr 1:83,479,168...83,497,011
Ensembl chr 1:83,479,147...83,487,169
|
|
|
G |
Cela2a |
chymotrypsin like elastase 2A |
|
ISO |
ClinVar Annotator: match by term: Abdominal obesity-metabolic syndrome 4 |
OMIM ClinVar |
PMID:25741868 PMID:31358993 |
|
NCBI chr 5:154,126,879...154,136,630
Ensembl chr 5:154,126,878...154,136,632
|
|
|
G |
Phf6 |
PHD finger protein 6 |
|
ISO ISS |
ClinVar Annotator: match by term: Borjeson-Forssman-Lehmann syndrome | ClinVar Annotator: match by term: MENTAL RETARDATION, EPILEPSY, AND ENDOCRINE DISORDERS | ClinVar Annotator: match by term: Mental deficiency, epilepsy and endocrine disorders OMIM:301900 CTD Direct Evidence: marker/mechanism |
OMIM ClinVar MouseDO CTD |
PMID:12415272 PMID:13871358 PMID:15241480 PMID:15466013 PMID:15580208 PMID:15994862 PMID:18414213 PMID:23906836 PMID:24092917 PMID:24728327 PMID:25099957 PMID:25741868 PMID:25741869 PMID:26648834 PMID:27633282 PMID:27698851 PMID:28492532 PMID:28539120 PMID:28554332 PMID:30403997 PMID:30630810 PMID:33772537 PMID:34041787 PMID:35662002 PMID:36999477 More...
|
|
NCBI chr X:132,656,658...132,699,720
Ensembl chr X:132,656,672...132,699,127
|
|
|
G |
Aff4 |
ALF transcription elongation factor 4 |
|
ISO |
ClinVar Annotator: match by term: AFF4-related condition | ClinVar Annotator: match by term: Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome |
OMIM ClinVar |
PMID:9536098 PMID:17576681 PMID:25730767 PMID:25741868 PMID:28492532 PMID:29758562 PMID:31058441 PMID:34782754 More...
|
|
NCBI chr10:37,498,825...37,579,751
Ensembl chr10:37,498,825...37,579,751
|
|
|
G |
Trip12 |
thyroid hormone receptor interactor 12 |
|
ISO |
ClinVar Annotator: match by term: Clark-Baraitser syndrome | ClinVar Annotator: match by term: TRIP12-related condition |
OMIM ClinVar |
PMID:3812552 PMID:25363768 PMID:25741868 PMID:27848077 PMID:28251352 PMID:28492532 PMID:28660352 PMID:29758562 PMID:31814248 More...
|
|
NCBI chr 9:85,916,691...86,043,312
Ensembl chr 9:85,916,691...86,051,403
|
|
|
G |
Ankrd46 |
ankyrin repeat domain 46 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:67,647,202...67,668,180
Ensembl chr 7:67,647,204...67,668,132
|
|
G |
Atp6v1c1 |
ATPase H+ transporting V1 subunit C1 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:69,834,464...69,872,278
Ensembl chr 7:69,834,463...69,872,278
|
|
G |
Azin1 |
antizyme inhibitor 1 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:69,654,773...69,681,578
Ensembl chr 7:69,654,663...69,681,578
|
|
G |
Baalc |
BAALC binder of MAP3K1 and KLF4 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:69,918,998...69,992,289
Ensembl chr 7:69,918,998...69,992,288
|
|
G |
Cox6c |
cytochrome c oxidase subunit 6C |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:67,129,265...67,142,001
Ensembl chr 7:67,111,024...67,141,963
|
|
G |
Cthrc1 |
collagen triple helix repeat containing 1 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:70,122,474...70,132,756
Ensembl chr 7:70,122,474...70,132,756
|
|
G |
Dcaf13 |
DDB1 and CUL4 associated factor 13 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:70,160,983...70,196,142
Ensembl chr 7:70,160,941...70,196,142
|
|
G |
Dcstamp |
dendrocyte expressed seven transmembrane protein |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:70,807,455...70,822,067
Ensembl chr 7:70,807,581...70,822,078
|
|
G |
Dpys |
dihydropyrimidinase |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231
|
|
G |
Fbxo43 |
F-box protein 43 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:67,333,161...67,346,751
Ensembl chr 7:67,333,162...67,346,751
|
|
G |
Fzd6 |
frizzled class receptor 6 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:70,055,012...70,086,781
Ensembl chr 7:70,055,068...70,086,776
|
|
G |
Grhl2 |
grainyhead-like transcription factor 2 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:68,400,287...68,530,269
Ensembl chr 7:68,400,477...68,530,258
|
|
G |
Kcns2 |
potassium voltage-gated channel, modifier subfamily S, member 2 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:15141358 PMID:16648375 PMID:20461111 PMID:28492532 |
|
NCBI chr 7:66,022,352...66,028,422
Ensembl chr 7:66,022,352...66,028,422
|
|
G |
Klf10 |
KLF transcription factor 10 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
|
|
G |
Lrp12 |
LDL receptor related protein 12 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:70,941,068...71,012,409
Ensembl chr 7:70,941,068...71,012,441
|
|
G |
Mir875 |
microRNA 875 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:15141358 PMID:16648375 PMID:20461111 PMID:28492532 |
|
NCBI chr 7:66,861,955...66,862,027
Ensembl chr 7:66,861,955...66,862,027
|
|
G |
Myo7a |
myosin VIIA |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:9382091 PMID:24033266 PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chr 1:152,342,611...152,414,171
Ensembl chr 1:152,344,448...152,414,157
|
|
G |
Ncald |
neurocalcin delta |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:68,532,671...68,964,740
Ensembl chr 7:68,534,421...68,964,496
|
|
G |
Nipal2 |
NIPA-like domain containing 2 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:65,774,477...65,884,807
Ensembl chr 7:65,774,477...65,884,807
|
|
G |
Odf1 |
outer dense fiber of sperm tails 1 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:69,377,427...69,389,662
Ensembl chr 7:69,380,116...69,389,664
|
|
G |
Osr2 |
odd-skipped related transciption factor 2 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:15141358 PMID:16648375 PMID:20461111 PMID:28492532 |
|
NCBI chr 7:66,487,841...66,495,003
Ensembl chr 7:66,487,839...66,495,224
|
|
G |
Pabpc1 |
poly(A) binding protein, cytoplasmic 1 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:67,777,438...67,789,731
Ensembl chr 7:67,777,381...67,789,744
|
|
G |
Polr2k |
RNA polymerase II, I and III subunit K |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:67,347,118...67,359,466
Ensembl chr 7:67,356,113...67,357,668
|
|
G |
Pop1 |
POP1 homolog, ribonuclease P/MRP subunit |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:65,705,348...65,733,143
Ensembl chr 7:65,705,368...65,733,141
|
|
G |
Rgs22 |
regulator of G-protein signaling 22 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:67,188,531...67,308,805
Ensembl chr 7:67,188,519...67,308,875
|
|
G |
Rims2 |
regulating synaptic membrane exocytosis 2 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:70,248,104...70,759,134
Ensembl chr 7:70,243,872...70,757,491
|
|
G |
Rnf19a |
ring finger protein 19A, RBR E3 ubiquitin protein ligase |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:67,425,833...67,465,214
Ensembl chr 7:67,425,837...67,465,222
|
|
G |
Rrm2b |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
|
|
G |
Slc25a32 |
solute carrier family 25 member 32 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:70,142,958...70,160,726
Ensembl chr 7:70,142,964...70,160,770
|
|
G |
Snx31 |
sorting nexin 31 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:67,676,514...67,776,925
Ensembl chr 7:67,676,524...67,732,086
|
|
G |
Spag1 |
sperm associated antigen 1 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome | ClinVar Annotator: match by term: VPS13B-related condition |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 7:67,361,474...67,421,369
Ensembl chr 7:67,361,477...67,421,368
|
|
G |
Stk3 |
serine/threonine kinase 3 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:15141358 PMID:16648375 PMID:20461111 PMID:28492532 |
|
NCBI chr 7:66,053,209...66,323,292
Ensembl chr 7:66,052,345...66,323,233
|
|
G |
Ubr5 |
ubiquitin protein ligase E3 component n-recognin 5 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:69,115,216...69,224,843
Ensembl chr 7:69,116,761...69,224,903
|
|
G |
Vps13b |
vacuolar protein sorting 13 homolog B |
|
ISO ISS |
ClinVar Annotator: match by term: Cohen syndrome | ClinVar Annotator: match by term: Pepper syndrome | ClinVar Annotator: match by term: VPS13B-related condition OMIM:216550 CTD Direct Evidence: marker/mechanism |
OMIM ClinVar MouseDO CTD |
PMID:9536098 PMID:11169562 PMID:12730828 PMID:15141358 PMID:15154116 PMID:15173253 PMID:15211651 PMID:15498460 PMID:15691367 PMID:15918062 PMID:16199547 PMID:16648375 PMID:16917849 PMID:17383910 PMID:17576681 PMID:17786118 PMID:17990063 PMID:18414213 PMID:18655112 PMID:19006247 PMID:19190672 PMID:19533689 PMID:19763152 PMID:20307669 PMID:20461111 PMID:20656880 PMID:20683995 PMID:20921020 PMID:21330571 PMID:21659346 PMID:21850686 PMID:21865173 PMID:22382802 PMID:22406018 PMID:22527104 PMID:22700954 PMID:22855652 PMID:23033978 PMID:23188044 PMID:23352163 PMID:23757202 PMID:24033266 PMID:24311531 PMID:24334746 PMID:24334764 PMID:25060287 PMID:25326635 PMID:25356970 PMID:25472526 PMID:25502226 PMID:25525159 PMID:25533962 PMID:25640679 PMID:25741868 PMID:26104215 PMID:26133662 PMID:26395554 PMID:26443248 PMID:26467025 PMID:26539891 PMID:26938784 PMID:27175599 PMID:27353947 PMID:27380831 PMID:27533158 PMID:27829003 PMID:28041643 PMID:28341476 PMID:28492532 PMID:28559085 PMID:28631888 PMID:28832562 PMID:29149870 PMID:29431110 PMID:29453417 PMID:29634382 PMID:29706646 PMID:29758347 PMID:30138938 PMID:30290665 PMID:30602132 PMID:30792901 PMID:30843084 PMID:31444703 PMID:31580008 PMID:31736247 PMID:31943017 PMID:31965297 PMID:32170714 PMID:32384097 PMID:32483926 PMID:32505691 PMID:32581362 PMID:32860008 PMID:32919079 PMID:32959227 PMID:33023636 PMID:33025479 PMID:33217554 PMID:33994118 PMID:34006472 PMID:34353225 PMID:34425733 PMID:35052368 PMID:35690661 More...
|
|
NCBI chr 7:66,557,862...67,128,429
Ensembl chr 7:66,558,471...67,128,429
|
|
G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:67,941,353...67,963,651
Ensembl chr 7:67,940,017...67,963,668
|
|
G |
Zfp706 |
zinc finger protein 706 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:68,167,496...68,174,121
Ensembl chr 7:68,166,323...68,174,148
|
|
G |
Zfpm2 |
zinc finger protein, multitype 2 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chr 7:71,678,658...72,116,209
Ensembl chr 7:71,678,880...72,116,205
|
|
|
G |
Lep |
leptin |
|
ISO |
ClinVar Annotator: match by term: LEP-related condition | ClinVar Annotator: match by term: Leptin dysfunction | ClinVar Annotator: match by term: Obesity due to congenital leptin deficiency |
OMIM ClinVar |
PMID:9202122 PMID:9500540 PMID:9745435 PMID:12393845 PMID:15070752 PMID:15472169 PMID:15937081 PMID:20140086 PMID:25551525 PMID:25741868 PMID:28209183 PMID:28377240 PMID:28492532 PMID:37314706 More...
|
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lepr |
leptin receptor |
|
ISO |
ClinVar Annotator: match by term: Obesity due to congenital leptin deficiency |
ClinVar |
PMID:25741868 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
|
G |
Irak1bp1 |
interleukin-1 receptor-associated kinase 1 binding protein 1 |
|
ISO |
ClinVar Annotator: match by term: DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHISM | ClinVar Annotator: match by term: PHIP-related disorder |
ClinVar |
PMID:9536098 PMID:17576681 PMID:23033978 PMID:25741868 PMID:28492532 PMID:29209020 PMID:32801363 PMID:33004838 More...
|
|
NCBI chr 8:83,731,512...83,748,289
Ensembl chr 8:83,731,507...83,748,289
|
|
G |
Phip |
pleckstrin homology domain interacting protein |
|
ISO |
ClinVar Annotator: match by term: DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHISM | ClinVar Annotator: match by term: PHIP-related disorder |
OMIM ClinVar |
PMID:9536098 PMID:16199547 PMID:17576681 PMID:23033978 PMID:25741868 PMID:27479843 PMID:27900362 PMID:28263302 PMID:28492532 PMID:29209020 PMID:32801363 PMID:33004838 PMID:34773373 More...
|
|
NCBI chr 8:83,776,802...83,891,192
Ensembl chr 8:83,781,465...83,894,283
|
|
|
G |
Lepr |
leptin receptor |
|
ISO |
ClinVar Annotator: match by term: LEPR-related condition | ClinVar Annotator: match by term: Leptin receptor deficiency |
OMIM ClinVar |
PMID:8666155 PMID:9144432 PMID:9537324 PMID:9860295 PMID:11354636 PMID:11380591 PMID:11443193 PMID:12006639 PMID:12646666 PMID:15585384 PMID:16284652 PMID:17229951 PMID:17785359 PMID:18212354 PMID:18490929 PMID:18703626 PMID:21393862 PMID:21744741 PMID:22331430 PMID:22810975 PMID:23616257 PMID:24319006 PMID:24611737 PMID:25741868 PMID:25751111 PMID:26094658 PMID:26467025 PMID:28492532 PMID:29970488 PMID:30926952 PMID:31237021 PMID:33221380 PMID:34097736 More...
|
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Leprot |
leptin receptor overlapping transcript |
|
ISO |
ClinVar Annotator: match by term: Leptin receptor deficiency |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 5:116,289,843...116,301,951
Ensembl chr 5:116,289,822...116,301,988
|
|
|
G |
Eif2s3 |
eukaryotic translation initiation factor 2 subunit gamma |
|
ISO |
ClinVar Annotator: match by term: MEHMO syndrome CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:23063529 PMID:25741868 PMID:25741869 PMID:27333055 PMID:28055140 PMID:30878599 More...
|
|
NCBI chr X:58,916,513...58,939,923
Ensembl chr X:58,917,490...58,940,686
|
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
treatment |
ISO |
|
RGD |
PMID:22384010 |
RGD:13831306 |
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Adcy3 |
adenylate cyclase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29311637 |
|
NCBI chr 6:27,100,089...27,203,686
Ensembl chr 6:27,124,828...27,203,686
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
treatment |
ISO |
|
RGD |
PMID:22828946 |
RGD:7243249 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Apln |
apelin |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent protein:increased expression:plasma |
RGD |
PMID:19756893 PMID:15970339 |
RGD:2313938, RGD:1600932 |
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
|
|
G |
Aqp7 |
aquaporin 7 |
|
ISO |
mRNA:decreased expression:subcutaneous adipose tissue |
RGD |
PMID:17566090 |
RGD:1626289 |
NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
|
|
G |
Bbs4 |
Bardet-Biedl syndrome 4 |
susceptibility |
ISO |
DNA:SNPs |
RGD |
PMID:17003356 |
RGD:1601311 |
NCBI chr 8:59,731,912...59,765,408
Ensembl chr 8:59,731,912...59,765,607
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21708048 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Cck |
cholecystokinin |
|
ISO |
|
RGD |
PMID:17443025 |
RGD:1625798 |
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
|
|
G |
Cpe |
carboxypeptidase E |
|
ISO |
mRNA:increased expression:visceral abdominal fat:significantly higher expression in visceral fat than subcutaneous fat of morbidly obese subjects |
RGD |
PMID:12530526 |
RGD:1626182 |
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
|
|
G |
Ctnnbl1 |
catenin, beta like 1 |
susceptibility no_association |
ISO |
DNA:snps:introns:IVS7+3134G>T, IVS7-79A>G (rs6013029, rs6020846) (human) |
RGD |
PMID:19245693 PMID:19228371 |
RGD:9850251, RGD:9850253 |
NCBI chr 3:146,387,940...146,548,987
Ensembl chr 3:146,387,889...146,548,987
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
|
RGD |
PMID:12883487 |
RGD:1626305 |
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
|
RGD |
PMID:19188925 |
RGD:2313745 |
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
mRNA:increased expression:subcutaneous adipose tissue |
RGD |
PMID:16046292 |
RGD:1626320 |
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:11889184 |
RGD:1626666 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Kcnma1 |
potassium calcium-activated channel subfamily M alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21708048 |
|
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
|
|
G |
Ksr2 |
kinase suppressor of ras 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr12:38,802,796...39,187,809
Ensembl chr12:38,802,004...39,188,375
|
|
G |
Lep |
leptin |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:9500540 PMID:15070752 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lepr |
leptin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9537324 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Lpin1 |
lipin 1 |
|
ISO |
|
RGD |
PMID:17563064 |
RGD:1641822 |
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Mc4r |
melanocortin 4 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:29273807 PMID:29311635 PMID:11443223 PMID:12588803 |
RGD:1600755, RGD:1600750 |
NCBI chr18:60,419,832...60,421,719
Ensembl chr18:60,419,832...60,421,719
|
|
G |
Mchr1 |
melanin-concentrating hormone receptor 1 |
onset |
ISO |
DNA:SNP:promoter |
RGD |
PMID:16186414 |
RGD:1624359 |
NCBI chr 7:112,761,554...112,764,746
Ensembl chr 7:112,761,554...112,764,032
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:17273651 |
RGD:1642195 |
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Npy2r |
neuropeptide Y receptor Y2 |
|
ISO |
|
RGD |
PMID:15855352 |
RGD:1642381 |
NCBI chr 2:167,901,999...167,912,165
Ensembl chr 2:167,903,879...167,905,024
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
onset |
ISO |
|
RGD |
PMID:16702999 |
RGD:1626135 |
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
ISO |
|
RGD |
PMID:11874690 |
RGD:1357926 |
NCBI chr 2:4,395,543...4,442,434
Ensembl chr 2:4,395,543...4,442,434
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
|
RGD |
PMID:11874690 |
RGD:1357926 |
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISO |
ClinVar Annotator: match by term: Morbid obesity |
ClinVar |
PMID:9753710 PMID:10690291 PMID:25157153 PMID:28492532 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ucp3 |
uncoupling protein 3 |
|
ISO |
ClinVar Annotator: match by term: OBESITY, SEVERE |
ClinVar |
PMID:9769326 PMID:25741868 PMID:28492532 |
|
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
|
|
|
G |
Cep19 |
centrosomal protein 19 |
|
ISO |
ClinVar Annotator: match by term: Morbid obesity and spermatogenic failure |
OMIM ClinVar |
PMID:24268657 PMID:25741868 PMID:28492532 |
|
NCBI chr11:68,677,869...68,687,117
Ensembl chr11:68,677,871...68,687,022
|
|
|
G |
Inpp5e |
inositol polyphosphate-5-phosphatase E |
|
ISO |
ClinVar Annotator: match by term: INPP5E-related condition | ClinVar Annotator: match by term: MORM syndrome CTD Direct Evidence: marker/mechanism DNA:nonsense mutation:exon:p.Q627X (c.1879C>T) (human) |
OMIM ClinVar CTD RGD |
PMID:9536098 PMID:15786477 PMID:17576681 PMID:19668215 PMID:19668216 PMID:23034536 PMID:23386033 PMID:23847139 PMID:25741868 PMID:26092869 PMID:26748598 PMID:27401686 PMID:28125082 PMID:28454995 PMID:28492532 PMID:28559085 PMID:28771248 PMID:29186038 PMID:29555955 PMID:29915382 PMID:29987673 PMID:33749171 PMID:34188062 PMID:34234304 PMID:36909829 PMID:19668215 More...
|
RGD:12911209 |
NCBI chr 3:9,216,776...9,229,539
Ensembl chr 3:9,216,776...9,229,450
|
|
|
G |
Aacs |
acetoacetyl-CoA synthetase |
|
IEP |
mRNA:altered expression:thalamus, hypothalamus (rat) |
RGD |
PMID:19219059 |
RGD:2326191 |
NCBI chr12:31,113,098...31,156,411
Ensembl chr12:31,113,098...31,160,954
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
susceptibility disease_progression |
ISO IEP |
DNA:SNP:exon:p.R230C (rs9282541) (human) mRNA:increased expression:liver (rat) |
RGD |
PMID:17287470 PMID:25612518 |
RGD:1601092, RGD:15045599 |
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
|
ISO |
|
RGD |
PMID:21726512 |
RGD:14688050 |
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
disease_progression |
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:25612518 |
RGD:15045599 |
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
|
ISO |
|
RGD |
PMID:15331430 |
RGD:1601095 |
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
|
|
G |
Acacb |
acetyl-CoA carboxylase beta |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:left ventricle myocardium (rat) |
CTD RGD |
PMID:20882379 PMID:33310031 |
RGD:329955450 |
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Ace |
angiotensin I converting enzyme |
no_association |
IEP ISO |
protein:increased expression:liver |
RGD |
PMID:19361967 PMID:17164796 |
RGD:2325227, RGD:1601115 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Ache |
acetylcholinesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acly |
ATP citrate lyase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
treatment |
IEP |
|
RGD |
PMID:30298849 |
RGD:401960083 |
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acp1 |
acid phosphatase 1 |
severity |
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent |
RGD |
PMID:2373509 PMID:9198310 |
RGD:1625289, RGD:2313187 |
NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
ISO IEP |
mRNA:decreased expression:subcutaneous adipose tissue mRNA, protein:increased expression:adipose tissue, liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20882379 PMID:16788709 PMID:1543733 |
RGD:1625735, RGD:1625737 |
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Ada |
adenosine deaminase |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:16501670 |
RGD:1624289 |
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
|
|
G |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
|
IMP |
associated with Hyperphagia |
RGD |
PMID:17567573 |
RGD:10450894 |
NCBI chr20:11,222,569...11,350,854
Ensembl chr20:11,222,583...11,350,852
|
|
G |
Adcy3 |
adenylate cyclase 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: ADCY3-related condition |
CTD ClinVar RGD |
PMID:9536098 PMID:17576681 PMID:25741868 PMID:28492532 PMID:29311635 PMID:30568259 More...
|
RGD:407550184 |
NCBI chr 6:27,100,089...27,203,686
Ensembl chr 6:27,124,828...27,203,686
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
IEP ISO |
associated with Pulmonary Disease, Chronic Obstructive; protein:decreased expression:plasma associated with myocardial infarction; protein:decreased expression:plasma associated with Diabetes Mellitus, Type 2 CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:10092513 PMID:14617771 PMID:16092047 PMID:19606374 PMID:18303100 PMID:18651432 PMID:23731386 PMID:28843383 More...
|
RGD:1599149, RGD:2313239, RGD:5686809, RGD:5686813, RGD:8695927, RGD:14975146 |
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adipor1 |
adiponectin receptor 1 |
|
IEP ISO |
mRNA:increased expression:liver mRNA:decreased expression:lymphocyte |
RGD |
PMID:16483885 PMID:17391161 |
RGD:1625763, RGD:1625761 |
NCBI chr13:45,859,461...45,879,248
Ensembl chr13:45,859,533...45,879,241
|
|
G |
Adipor2 |
adiponectin receptor 2 |
treatment severity |
IEP |
mRNA:increased expression:liver mRNA:decreased expression:liver (rat) associated with non-alcoholic fatty liver disease |
RGD |
PMID:16483885 PMID:30225267 PMID:23838384 PMID:30131158 |
RGD:1625763, RGD:21406435, RGD:8695926, RGD:25824942 |
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Adm |
adrenomedullin |
|
ISO |
mRNA, protein:increased expression:adipose tissue |
RGD |
PMID:16793965 |
RGD:1625297 |
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adora1 |
adenosine A1 receptor |
|
ISO |
|
RGD |
PMID:16507638 |
RGD:1625369 |
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
|
|
G |
Adra2a |
adrenoceptor alpha 2A |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
|
|
G |
Adra2b |
adrenoceptor alpha 2B |
|
ISO |
|
RGD |
PMID:10404816 |
RGD:1300265 |
NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:114,585,169...114,589,355
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12032746 |
|
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
susceptibility no_association |
ISO |
DNA:polymorphisms: :p.R16G, p.Q27E CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15687340 PMID:17027833 PMID:17221209 PMID:15118671 PMID:12161655 |
RGD:1601122, RGD:1601119, RGD:1331525, RGD:737773 |
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Adrb3 |
adrenoceptor beta 3 |
no_association susceptibility |
ISO |
DNA:missense mutation:cds:p.W64R (human) mRNA:decreased expression:interscapular region, brown adipose tissue (mouse) DNA:missense mutation:cds:p.W64R rs4994 (human) DNA:polymorphisms, haplotype:cds, intron, 3' utr:g.827T>C rs4994, g.1856G>T, g.3139G>C (human) ClinVar Annotator: match by term: Obesity CTD Direct Evidence: marker/mechanism |
ClinVar OMIM CTD RGD |
PMID:7609750 PMID:7609752 PMID:8903328 PMID:8954053 PMID:9054940 PMID:9100608 PMID:9112025 PMID:9449691 PMID:9709965 PMID:9814483 PMID:9892244 PMID:10323390 PMID:10323402 PMID:10999801 PMID:11095426 PMID:15472194 PMID:25741868 PMID:9126344 PMID:19373220 PMID:11882399 PMID:9892244 More...
|
RGD:1559325, RGD:5684359, RGD:5684409, RGD:5684773 |
NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552
|
|
G |
Aff4 |
ALF transcription elongation factor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25730767 |
|
NCBI chr10:37,498,825...37,579,751
Ensembl chr10:37,498,825...37,579,751
|
|
G |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
|
ISO |
|
RGD |
PMID:20068140 |
RGD:13838849 |
NCBI chr 7:62,897,282...62,914,295
Ensembl chr 7:62,897,282...62,914,295
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO |
protein:decreased expression:plasma (human) |
RGD |
PMID:23046363 PMID:22761461 |
RGD:7243247, RGD:7243250 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Agrp |
agouti related neuropeptide |
|
IEP ISO |
mRNA:increased expression:hypothalamus DNA:polymorphism:exon:c.199G>A, pAla67Thr (human) DNA:polymorphism:promoter:-38C>T (human) ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, late-onset CTD Direct Evidence: marker/mechanism DNA:SNP:T67A (rs5030980) (human) |
OMIM ClinVar CTD RGD |
PMID:11602360 PMID:12213871 PMID:15054840 PMID:25741868 PMID:18001323 PMID:12213871 PMID:11344185 PMID:11554767 PMID:15118671 PMID:23900445 More...
|
RGD:2311538, RGD:1625232, RGD:1300272, RGD:2314000, RGD:1331525, RGD:405650675 |
NCBI chr19:33,447,992...33,481,602
Ensembl chr19:33,447,992...33,449,584
|
|
G |
Agt |
angiotensinogen |
susceptibility |
ISO |
DNA:polymorphism: :p.M235T DNA:polymorphism: :p.T174M |
RGD |
PMID:16713443 PMID:16514903 |
RGD:1601142, RGD:1601143 |
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
|
ISO |
|
RGD |
PMID:15793237 |
RGD:2313554 |
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
|
|
G |
Ahi1 |
Abelson helper integration site 1 |
|
ISO |
mRNA:increased expression:vastus lateralis |
RGD |
PMID:20045148 |
RGD:11537398 |
NCBI chr 1:15,762,485...15,891,213
Ensembl chr 1:15,762,462...15,891,041
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27020609 PMID:30813227 PMID:31306034 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahsg |
alpha-2-HS-glycoprotein |
susceptibility |
ISO |
protein:increased expression:serum |
RGD |
PMID:17011519 PMID:19228823 PMID:17011519 |
RGD:1625793, RGD:2313809, RGD:1625793 |
NCBI chr11:78,121,388...78,127,998
Ensembl chr11:78,117,918...78,145,999
|
|
G |
Ak1 |
adenylate kinase 1 |
|
ISO |
protein:increased expression:skeletal muscle |
RGD |
PMID:15855311 |
RGD:1601154 |
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
|
|
G |
Akap1 |
A-kinase anchoring protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20975297 |
|
NCBI chr10:73,621,021...73,654,123
Ensembl chr10:73,621,883...73,653,896
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
ISO |
mRNA, protein:increased expression:adipose tissue |
RGD |
PMID:15494612 |
RGD:1626148 |
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
|
ISO |
mRNA, protein:increased expression:adipose tissue |
RGD |
PMID:15494612 |
RGD:1626148 |
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23954404 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
|
ISO IEP |
protein:decreased activity:rectus abdominis (human) protein:decreased expression:plantaris (rat) |
RGD |
PMID:12663464 PMID:17923673 PMID:18508911 |
RGD:2313409, RGD:2313406, RGD:2313320 |
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Alms1 |
ALMS1, centrosome and basal body associated protein |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr 4:118,125,581...118,226,005
Ensembl chr 4:118,125,607...118,226,005
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
|
IEP ISO |
mRNA:increased expression:adipose tissue, fat cell |
RGD |
PMID:20978234 PMID:18780776 |
RGD:5509594, RGD:5509628 |
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
ISO |
mRNA:increased expression:adipose tissue (mouse) mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:17379835 PMID:19596146 |
RGD:2313913, RGD:2313884 |
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
|
|
G |
Amh |
anti-Mullerian hormone |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:17109858 |
RGD:1601182 |
NCBI chr 7:8,906,776...8,909,192
Ensembl chr 7:8,906,836...8,909,282
|
|
G |
Ang |
angiogenin |
|
ISO |
protein:increased expression:adipose tissue |
RGD |
PMID:22748184 |
RGD:6892722 |
NCBI chr15:24,312,711...24,323,361
|
|
G |
Angptl4 |
angiopoietin-like 4 |
resistance |
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:28842503 PMID:17210919 |
RGD:1625353 |
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Angptl6 |
angiopoietin-like 6 |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr 8:19,413,617...19,419,925
Ensembl chr 8:19,413,619...19,419,925
|
|
G |
Ankrd26 |
ankyrin repeat domain containing 26 |
|
ISO ISS |
OMIM:601665 |
MouseDO RGD |
PMID:18162531 |
RGD:9681744 |
NCBI chr 4:151,670,604...151,740,032
Ensembl chr 4:151,672,037...151,739,968
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
|
IMP |
|
RGD |
PMID:17977742 |
RGD:2313916 |
NCBI chr10:86,272,757...86,280,702
|
|
G |
Apcdd1 |
APC down-regulated 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28242765 |
|
NCBI chr18:56,385,398...56,416,065
Ensembl chr18:56,385,264...56,416,070
|
|
G |
Apln |
apelin |
|
IEP |
mRNA:increased expression:subcutaneous adipose tissue |
RGD |
PMID:17594060 |
RGD:1626170 |
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
protein:decreased expression |
RGD |
PMID:9933608 PMID:12725089 |
RGD:2313959, RGD:1601185 |
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoa2 |
apolipoprotein A2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9933608 PMID:9002300 |
RGD:2313959, RGD:1601191 |
NCBI chr13:83,644,460...83,646,358
Ensembl chr13:83,644,470...83,646,355
|
|
G |
Apoa4 |
apolipoprotein A4 |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apoa5 |
apolipoprotein A5 |
|
ISO |
DNA:SNP: :rs662799 (human) |
GAD RGD |
PMID:15118671 PMID:25606423 |
RGD:1331525, RGD:329901774 |
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
|
|
G |
Apob |
apolipoprotein B |
|
ISO |
associated with Insulin Resistance;protein:increased expression:plasma |
RGD GAD |
PMID:19592617 PMID:15118671 |
RGD:2313974, RGD:1331525 |
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apobec1 |
apolipoprotein B mRNA editing enzyme catalytic subunit 1 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:8781289 |
RGD:1626278 |
NCBI chr 4:155,800,030...155,828,515
Ensembl chr 4:155,800,887...155,827,390
|
|
G |
Apoc1 |
apolipoprotein C1 |
|
ISO |
|
RGD |
PMID:11723061 |
RGD:2313951 |
NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
|
|
G |
Apoc2 |
apolipoprotein C2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9002300 |
RGD:1601191 |
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
|
|
G |
Apoc3 |
apolipoprotein C3 |
|
ISO |
protein:increased expression:serum |
RGD GAD |
PMID:9002300 PMID:15118671 |
RGD:1601191, RGD:1331525 |
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
Apod |
apolipoprotein D |
|
ISO |
DNA:polymorphism |
RGD |
PMID:7913935 |
RGD:2311179 |
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20975297 PMID:9002300 PMID:15118671 PMID:17192461 |
RGD:1601191, RGD:1331525, RGD:1601230 |
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
treatment |
ISO |
mRNA,protein:increased expression:adipocyte,plasma: |
RGD |
PMID:19672057 |
RGD:10054260 |
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp7 |
aquaporin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16325777 |
|
NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
|
|
G |
Ar |
androgen receptor |
susceptibility |
ISO ISS |
DNA:repeats: :GGN, CAG associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:repeat: :CAG OMIM:601665 |
MouseDO RGD |
PMID:12532157 PMID:15118671 PMID:18805913 |
RGD:1601246, RGD:1331525, RGD:2306771 |
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arl13b |
ADP-ribosylation factor like GTPase 13B |
|
ISO |
protein:decreased expression:hypothalamus, cilium (mouse) |
RGD |
PMID:22581473 |
RGD:11553936 |
NCBI chr11:150,100...217,103
Ensembl chr11:150,955...217,197
|
|
G |
Asip |
agouti signaling protein |
susceptibility |
ISO ISS |
DNA, mRNA:deletion, insertions, increased expression: multiple organs OMIM:601665 CTD Direct Evidence: marker/mechanism |
MouseDO CTD RGD |
PMID:1473152 PMID:8146154 PMID:25447408 PMID:25448685 PMID:32937126 PMID:7987393 More...
|
RGD:1625724 |
NCBI chr 3:143,473,584...143,561,170
Ensembl chr 3:143,555,696...143,561,171
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
susceptibility |
ISO |
|
RGD |
PMID:16286513 |
RGD:1601250 |
NCBI chr13:84,729,597...84,754,544
Ensembl chr13:84,729,601...84,754,544
|
|
G |
Atp4b |
ATPase H+/K+ transporting subunit beta |
treatment |
IDA |
|
RGD |
PMID:25822172 |
RGD:14696745 |
NCBI chr16:76,144,150...76,153,063
Ensembl chr16:76,144,150...76,153,063
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
treatment |
IDA |
|
RGD |
PMID:26880535 |
RGD:13782133 |
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Atp5f1c |
ATP synthase F1 subunit gamma |
|
ISO |
|
RGD |
PMID:19549744 |
RGD:14696798 |
NCBI chr17:68,423,927...68,446,169
Ensembl chr17:68,423,909...68,608,367
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
treatment |
IDA |
|
RGD |
PMID:27874268 |
RGD:13792665 |
NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
|
|
G |
Atp5mc2 |
ATP synthase membrane subunit c locus 2 |
|
ISO |
|
RGD |
PMID:26709097 |
RGD:11535661 |
NCBI chr 7:133,791,341...133,799,713
Ensembl chr 7:133,791,342...133,799,733
|
|
G |
Atpaf1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 5:129,265,789...129,292,463
Ensembl chr 5:129,266,404...129,293,556
|
|
G |
Atrn |
attractin |
|
ISO |
|
RGD |
PMID:10086355 |
RGD:734623 |
NCBI chr 3:118,110,320...118,244,326
Ensembl chr 3:118,110,229...118,244,322
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
ISO IEP |
associated with colorectal cancer; protein:decreased expression:subcutaneous white adipose tissue protein:decreased expression:plasma mRNA, protein:decreased expression:fat pad, liver,plasma mRNA:decreased expression:fat pad |
RGD |
PMID:29755407 PMID:21136593 PMID:19934249 PMID:19934249 |
RGD:153350147, RGD:153350156, RGD:153350157, RGD:153350157 |
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
|
|
G |
B2m |
beta-2 microglobulin |
|
ISO |
protein:increased expression:urine |
RGD |
PMID:15517379 |
RGD:1601309 |
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
Bad |
BCL2-associated agonist of cell death |
|
IEP |
protein:increased expression:heart left ventricle |
RGD |
PMID:18070754 |
RGD:2292682 |
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
|
ISO |
mRNA:decreased expression:adipose tissue |
RGD |
PMID:22187378 |
RGD:14390162 |
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Bbs1 |
Bardet-Biedl syndrome 1 |
no_association |
ISO ISS |
DNA:mutation: :p.M390R (human) OMIM:601665 |
MouseDO RGD |
PMID:14993910 PMID:33722691 |
RGD:1601314, RGD:243065268 |
NCBI chr 1:202,184,812...202,204,118
Ensembl chr 1:202,186,125...202,204,086
|
|
G |
Bbs2 |
Bardet-Biedl syndrome 2 |
susceptibility |
ISO |
DNA:SNPs |
RGD |
PMID:17003356 |
RGD:1601311 |
NCBI chr19:10,909,653...10,944,998
Ensembl chr19:10,909,619...10,944,993
|
|
G |
Bbs4 |
Bardet-Biedl syndrome 4 |
onset |
ISO ISS |
DNA:SNPs OMIM:601665 |
MouseDO RGD |
PMID:17003356 |
RGD:1601311 |
NCBI chr 8:59,731,912...59,765,408
Ensembl chr 8:59,731,912...59,765,607
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:18452903 PMID:23000450 PMID:23073171 PMID:27163854 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
IEP |
mRNA, protein:decreased expression:heart left ventricle |
RGD |
PMID:18202171 |
RGD:2293027 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
|
ISO |
|
RGD |
PMID:17184856 |
RGD:1625733 |
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
ISO |
protein:decreased expression:plasma ClinVar Annotator: match by term: Obesity |
ClinVar RGD |
PMID:11840487 PMID:25741868 PMID:28492532 PMID:17151862 |
RGD:10059350 |
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
|
IEP |
|
RGD |
PMID:18070754 |
RGD:2292682 |
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Brd2 |
bromodomain containing 2 |
|
ISO |
|
RGD |
PMID:19883376 |
RGD:9586446 |
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
|
|
G |
Brs3 |
bombesin receptor subtype 3 |
|
ISO |
|
RGD |
PMID:9367152 |
RGD:734661 |
NCBI chr X:134,906,817...134,932,321
Ensembl chr X:134,906,784...134,930,983
|
|
G |
C3 |
complement C3 |
treatment |
IDA |
|
RGD |
PMID:23118029 |
RGD:7411625 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C5ar1 |
complement C5a receptor 1 |
treatment |
IDA |
|
RGD |
PMID:23118029 |
RGD:7411625 |
NCBI chr 1:76,948,622...76,959,826
|
|
G |
Cadm2 |
cell adhesion molecule 2 |
|
ISO |
DNA:SNP: :rs13078807 (human) |
RGD |
PMID:31341224 |
RGD:15092077 |
NCBI chr11:4,548,367...5,525,420
Ensembl chr11:4,555,159...5,525,400
|
|
G |
Canx |
calnexin |
|
ISO |
protein:increased expression:subcutaneous adipose tissue |
RGD |
PMID:18567819 |
RGD:2314284 |
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
|
|
G |
Capn10 |
calpain 10 |
|
ISO |
DNA:SNPs |
RGD |
PMID:16752174 |
RGD:1625047 |
NCBI chr 9:93,498,132...93,510,494
Ensembl chr 9:93,498,478...93,510,494
|
|
G |
Car3 |
carbonic anhydrase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Cartpt |
CART prepropeptide |
no_association susceptibility |
ISO |
DNA:deletion, substitution: :1457delA, 1475A>G (human) DNA:missense mutation:exon:729G>C, p.L34F (human) DNA:polymorphism:3' utr (human) ClinVar Annotator: match by term: Obesity CTD Direct Evidence: marker/mechanism |
ClinVar OMIM CTD RGD |
PMID:11522684 PMID:15326462 PMID:25741868 PMID:10574510 PMID:11522684 PMID:10805512 More...
|
RGD:2313634, RGD:1625192, RGD:2313633 |
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
|
|
G |
Casp1 |
caspase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22325453 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Cast |
calpastatin |
|
ISO |
ClinVar Annotator: match by term: Body mass index quantitative trait locus 12 | ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Obesity due to SIM1 deficiency |
ClinVar |
PMID:18604207 PMID:22210313 PMID:23383060 PMID:25741868 PMID:28492532 |
|
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
|
|
G |
Cav1 |
caveolin 1 |
|
IEP |
|
RGD |
PMID:22492718 |
RGD:6784520 |
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Cav2 |
caveolin 2 |
|
IEP |
|
RGD |
PMID:22492718 |
RGD:6784520 |
NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:45,616,712...45,624,244
|
|
G |
Cckar |
cholecystokinin A receptor |
|
IAGP ISO |
DNA:deletion |
RGD |
PMID:9530226 PMID:9192855 |
RGD:7257724, RGD:734711 |
NCBI chr14:57,292,397...57,300,747
Ensembl chr14:57,292,397...57,300,747
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO IEP |
protein, mRNA:increased expression:plasma, fat protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:29035695 PMID:17803693 PMID:18469848 |
RGD:2306993, RGD:2307038 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
IEP |
|
RGD |
PMID:21862610 |
RGD:5683906 |
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:18469848 |
RGD:2307038 |
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
|
ISO |
|
RGD |
PMID:18492752 |
RGD:6483834 |
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
mRNA:increased expression:adipose tissue |
RGD |
PMID:18492752 |
RGD:6483834 |
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
|
|
G |
Cd163 |
CD163 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29035695 |
|
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd36 |
CD36 molecule |
|
IEP ISO IMP |
mRNA, protein:increased expression:liver, gastrocnemius protein:increased expression:skeletal muscle, T-tubule |
RGD |
PMID:20435456 PMID:22615812 PMID:23743348 PMID:25477422 |
RGD:6893497, RGD:6893542, RGD:11041118, RGD:11041132 |
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd40 |
CD40 molecule |
treatment |
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:29035695 PMID:21670556 |
RGD:7248753 |
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21817098 PMID:20660932 |
RGD:5490592, RGD:5490970 |
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cd68 |
Cd68 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29035695 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
susceptibility |
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:polymorphism:intron:IVS4-40G>A (human) |
RGD |
PMID:19634152 |
RGD:2314609 |
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr17:34,718,701...35,271,276
Ensembl chr17:34,718,687...35,407,524
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:23357529 |
RGD:10045356 |
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
IEP |
|
RGD |
PMID:22194422 |
RGD:8552660 |
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
|
ISO |
|
RGD |
PMID:16627576 |
RGD:2301355 |
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28242765 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cenpo |
centromere protein O |
|
ISO |
ClinVar Annotator: match by term: ADCY3-related condition |
ClinVar |
PMID:9536098 PMID:17576681 PMID:25741868 PMID:28492532 |
|
NCBI chr 6:27,203,642...27,218,394
Ensembl chr 6:27,188,537...27,218,314
|
|
G |
Cers1 |
ceramide synthase 1 |
|
ISO |
mRNA:increased expression:skeletal muscle cell |
RGD |
PMID:30605666 |
RGD:156431060 |
NCBI chr16:19,097,309...19,112,519
Ensembl chr16:19,104,466...19,112,519
|
|
G |
Ces1d |
carboxylesterase 1D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20975297 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cfd |
complement factor D |
|
IEP ISO |
mRNA, protein:decreased expression:adipocyte, serum |
RGD |
PMID:2197880 PMID:14564690 |
RGD:1624327, RGD:1624324 |
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20975297 PMID:16186410 |
RGD:1625390 |
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
no_association |
ISO IMP IEP |
DNA:polymorphism:exon:3813A>G (human) DNA:polymorphism: :1256C>A, 1419+1G>C (human) CTD Direct Evidence: marker/mechanism DNA, mRNA:hypermethylation, increased expression:promoter, hypothalamus DNA:hypermethylation:promoter, peripheral blood mononuclear cell |
CTD RGD |
PMID:18722357 PMID:17405839 PMID:17292652 PMID:19530697 PMID:19325539 PMID:31258545 PMID:31258545 More...
|
RGD:1626325, RGD:1626326, RGD:2314629, RGD:2314630, RGD:401827956, RGD:401827956 |
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cntf |
ciliary neurotrophic factor |
no_association |
ISO |
DNA:point mutation:intron:G>A |
RGD |
PMID:14747836 PMID:12404108 |
RGD:1626114, RGD:1626113 |
NCBI chr 1:209,887,854...209,889,877
Ensembl chr 1:209,887,854...209,889,877
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
IEP |
mRNA:increased expression:kidney (rat) |
RGD |
PMID:28746409 |
RGD:401965413 |
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
IEP |
mRNA:increased expression:kidney (rat) |
RGD |
PMID:28746409 |
RGD:401965413 |
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
|
IEP |
mRNA:increased expression:kidney (rat) |
RGD |
PMID:28746409 |
RGD:401965413 |
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Comt |
catechol-O-methyltransferase |
susceptibility |
ISO |
DNA:polymorphism:exon |
RGD |
PMID:17497175 |
RGD:2289713 |
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cox7c |
cytochrome c oxidase subunit 7C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 2:16,841,771...16,843,796
Ensembl chr 2:16,840,837...16,843,760
|
|
G |
Cox8b |
cytochrome c oxidase, subunit VIIIb |
|
IDA |
|
RGD |
PMID:16027000 |
RGD:2301397 |
NCBI chr 1:195,977,183...195,978,643
|
|
G |
Cpb2 |
carboxypeptidase B2 |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression, increased activity:plasma CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16959692 PMID:11836301 |
RGD:2313645 |
NCBI chr15:50,557,722...50,606,569
Ensembl chr15:50,557,717...50,606,556
|
|
G |
Cpe |
carboxypeptidase E |
no_association |
ISO ISS |
CTD Direct Evidence: marker/mechanism OMIM:601665 DNA:SNP:intron (rs1946816, rs4481204) (human) |
CTD MouseDO RGD |
PMID:15358678 PMID:23434795 PMID:9662053 PMID:7663508 PMID:23900445 |
RGD:1626184, RGD:1626181, RGD:405650675 |
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
|
IEP |
|
RGD |
PMID:15481768 |
RGD:2303517 |
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
treatment |
IEP |
mRNA:decreased expression:liver mRNA:decreased expression:left ventricle myocardium (rat) |
RGD |
PMID:16751799 PMID:33310031 |
RGD:2311345, RGD:329955450 |
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Crh |
corticotropin releasing hormone |
|
IDA |
|
RGD |
PMID:11564446 |
RGD:5508830 |
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Crhbp |
corticotropin releasing hormone binding protein |
|
IEP |
mRNA:decreased expression:anterior pituitary gland (rat) |
RGD |
PMID:10600923 |
RGD:5508840 |
NCBI chr 2:26,692,403...26,704,710
Ensembl chr 2:26,692,403...26,704,710
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
ISO |
DNA:SNP:CDS:861C>T (human) |
RGD |
PMID:14724656 |
RGD:1626226 |
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
|
|
G |
Crp |
C-reactive protein |
disease_progression |
ISO IEP |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (rat) |
CTD RGD |
PMID:24042701 PMID:20660932 PMID:25612518 |
RGD:5490970, RGD:15045599 |
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cs |
citrate synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Cst3 |
cystatin C |
|
IEP ISO |
protein:increased expression:plasma (rat) protein:increased expression:serum (human) |
RGD |
PMID:18946178 PMID:18374694 |
RGD:2314297, RGD:2314346 |
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
|
|
G |
Ctf1 |
cardiotrophin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21803294 |
|
NCBI chr 1:182,328,035...182,336,346
Ensembl chr 1:182,328,090...182,333,335
|
|
G |
Ctsc |
cathepsin C |
|
IEP |
|
RGD |
PMID:3705543 |
RGD:1599645 |
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
|
|
G |
Ctss |
cathepsin S |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21156398 |
|
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
DNA:SNP: :p.T280M (human) |
RGD |
PMID:20523302 |
RGD:4891903 |
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
|
ISO |
|
RGD |
PMID:25016030 |
RGD:13673852 |
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyb5a |
cytochrome b5 type A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cycs |
cytochrome c, somatic |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16317704 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27036855 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
susceptibility |
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:polymorphisms:promoter, intron:g.-1260C>A, g.2838T>C (human) |
RGD |
PMID:17223345 |
RGD:2307312 |
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:18589557 |
RGD:2301455 |
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
IEP ISO |
protein:increased activity:liver,fat CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23954404 PMID:17049493 |
RGD:1626307 |
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2r1 |
cytochrome P450, family 2, subfamily r, polypeptide 1 |
|
ISO |
associated with hypertension:DNA:SNP:CDS: rs12794714 (human) |
RGD |
PMID:34906413 |
RGD:401900724 |
NCBI chr 1:168,749,302...168,798,079
Ensembl chr 1:168,751,038...168,797,759
|
|
G |
Dcn |
decorin |
|
IEP |
|
RGD |
PMID:17244723 |
RGD:1600551 |
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr10:106,006,404...106,008,293
|
|
G |
Ddhd2 |
DDHD domain containing 2 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:23176823 PMID:24337409 PMID:24517879 PMID:25417924 PMID:25741868 PMID:28492532 PMID:32488064 More...
|
|
NCBI chr16:66,319,469...66,349,025
Ensembl chr16:66,319,466...66,349,023
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26655953 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Deaf1 |
DEAF1 transcription factor |
|
ISO |
ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 1:196,401,857...196,435,541
Ensembl chr 1:196,401,857...196,435,541
|
|
G |
Defb1 |
defensin beta 1 |
|
IEP |
mRNA:decreased expression:kidney |
RGD |
PMID:11340353 |
RGD:4892260 |
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
no_association treatment |
ISO |
|
RGD |
PMID:14569040 PMID:10802663 PMID:18183944 |
RGD:1625597, RGD:734536, RGD:10401058 |
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
no_association |
ISO |
|
RGD |
PMID:17077128 |
RGD:1626439 |
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
|
|
G |
Dip2c |
disco-interacting protein 2 homolog C |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr17:60,647,346...61,032,467
Ensembl chr17:60,649,065...61,032,305
|
|
G |
Dixdc1 |
DIX domain containing 1 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr 8:51,007,835...51,081,191
Ensembl chr 8:51,007,838...51,081,090
|
|
G |
Dnm1l |
dynamin 1-like |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:26825290 PMID:27328748 PMID:28492532 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:24614070 PMID:25741868 PMID:28492532 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Drd1 |
dopamine receptor D1 |
treatment |
IEP IDA |
protein:increased serine phosphorylation:renal proximal tubule, membrane (rat) |
RGD |
PMID:15983225 PMID:17191082 |
RGD:7248449, RGD:7248552 |
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
|
|
G |
Drd2 |
dopamine receptor D2 |
|
IEP ISO |
mRNA:decreased expression:ventral tegmental area (rat) DNA:polymorphisms, haplotype:enhancer, promoter, intron:multiple |
RGD |
PMID:18477764 PMID:17108814 PMID:15939106 |
RGD:2311581, RGD:1600904, RGD:1600905 |
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Drd4 |
dopamine receptor D4 |
|
ISO IEP |
protein:decreased expression:kidney (rat) |
GAD RGD |
PMID:15118671 PMID:20810614 |
RGD:1331525, RGD:7248616 |
NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
susceptibility |
ISO |
|
RGD |
PMID:16814733 |
RGD:2298673 |
NCBI chr10:16,680,478...16,683,275
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
treatment |
ISO |
|
RGD |
PMID:31961704 |
RGD:21408561 |
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Echs1 |
enoyl-CoA hydratase, short chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
DNA:polymorphism:exon:p.K198N (human) |
RGD |
PMID:17444275 |
RGD:1625065 |
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Efnb1 |
ephrin B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24098442 |
|
NCBI chr X:64,257,351...64,270,158
Ensembl chr X:64,257,351...64,270,157
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
protein:decreased phosphorylation:liver (mouse) |
RGD |
PMID:3624263 |
RGD:5131534 |
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ehd1 |
EH-domain containing 1 |
|
IEP |
|
RGD |
PMID:21365757 |
RGD:8661255 |
NCBI chr 1:203,579,850...203,602,226
Ensembl chr 1:203,579,869...203,602,212
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
|
ISO |
mRNA,protein:increased expression:liver: |
RGD |
PMID:31988048 |
RGD:21403676 |
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Emc1 |
ER membrane protein complex subunit 1 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:26572623 PMID:26942288 PMID:28492532 PMID:29271071 |
|
NCBI chr 5:151,608,557...151,633,888
Ensembl chr 5:151,608,568...151,633,888
|
|
G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
susceptibility |
ISO |
Obesity, OMIM:601665;DNA:polymorphism CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity disorder |
CTD ClinVar OMIM RGD |
PMID:9662402 PMID:10453738 PMID:10480624 PMID:11739459 PMID:11771660 PMID:12881724 PMID:14671192 PMID:14988267 PMID:15001634 PMID:15126519 PMID:15605415 PMID:15677494 PMID:16025115 PMID:16369898 PMID:16607460 PMID:16609882 PMID:16968801 PMID:18950909 PMID:20016754 PMID:20137773 PMID:20981035 PMID:22539483 PMID:24033266 PMID:25741868 PMID:27238374 PMID:28377967 PMID:28492532 PMID:29979387 PMID:35738466 PMID:16025115 More...
|
RGD:1601042 |
NCBI chr 1:20,698,746...20,763,741
Ensembl chr 1:20,698,764...20,763,715
|
|
G |
Entpd6 |
ectonucleoside triphosphate diphosphohydrolase 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr 3:139,575,659...139,598,163
Ensembl chr 3:139,575,686...139,598,154
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26441656 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO IDA |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20667977 PMID:11095962 PMID:22230815 |
RGD:8553065, RGD:8553199 |
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
|
IDA |
|
RGD |
PMID:22230815 |
RGD:8553199 |
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Esrra |
estrogen related receptor, alpha |
no_association |
ISO |
|
RGD |
PMID:16755280 |
RGD:1625637 |
NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268
|
|
G |
Etfdh |
electron transfer flavoprotein dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO IDA |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:22841818 PMID:21210148 PMID:23628972 |
RGD:5147773, RGD:7387310 |
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F7 |
coagulation factor VII |
|
ISO |
protein:increased activity:plasma (human) associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased activity:plasma (human) |
RGD |
PMID:19329212 PMID:16739871 PMID:14513073 PMID:9258277 |
RGD:2312379, RGD:1625710, RGD:2312395, RGD:2312404 |
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
|
|
G |
Faah |
fatty acid amide hydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19103437 PMID:20716455 PMID:15809662 |
RGD:1625726 |
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
|
ISO |
Western diet-induced obesity |
RGD |
PMID:17058218 |
RGD:1626440 |
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fabp2 |
fatty acid binding protein 2 |
onset no_association |
ISO |
DNA:polymorphism:CDS:p.A54T (human) |
RGD |
PMID:15620432 PMID:14981227 PMID:17211557 |
RGD:1578458, RGD:1626400, RGD:1626407 |
NCBI chr 2:211,040,032...211,044,089
Ensembl chr 2:211,040,032...211,044,089
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent;mRNA:decreased expression:skeletal muscle |
RGD |
PMID:17515913 |
RGD:2307328 |
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
|
ISO |
|
RGD |
PMID:8910278 |
RGD:737747 |
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fadd |
Fas associated via death domain |
|
IEP |
protein:increased expression:heart left ventricle |
RGD |
PMID:18202171 |
RGD:2293027 |
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fads1 |
fatty acid desaturase 1 |
|
IEP |
protein:decreased expression:microsomes, liver |
RGD |
PMID:8446010 |
RGD:1625421 |
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fanca |
FA complementation group A |
|
ISO |
|
RGD |
PMID:22482891 |
RGD:11046266 |
NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527
|
|
G |
Fancc |
FA complementation group C |
|
ISO |
|
RGD |
PMID:22482891 |
RGD:11046266 |
NCBI chr17:1,680,660...1,822,610
Ensembl chr17:1,681,324...1,829,376
|
|
G |
Fasn |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbxo11 |
F-box protein 11 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr 6:6,486,761...6,562,664
Ensembl chr 6:6,486,015...6,562,662
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24184811 PMID:26797127 |
|
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
IEP ISO |
mRNA:increased expression:hypothalamus: mRNA:increased expression:adipose tissue: |
RGD |
PMID:21430024 PMID:21430024 |
RGD:10402094, RGD:10402094 |
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgg |
fibrinogen gamma chain |
|
IEP |
protein:decreased expression:plasma |
RGD |
PMID:22134356 |
RGD:11352709 |
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Fggy |
FGGY carbohydrate kinase domain containing |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29220483 |
|
NCBI chr 5:110,398,866...110,786,019
Ensembl chr 5:110,398,863...110,786,017
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27071101 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxa2 |
forkhead box A2 |
|
ISO |
|
RGD |
PMID:12865419 |
RGD:1627574 |
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
|
|
G |
Foxc2 |
forkhead box C2 |
|
ISO |
DNA:polymorphism:5'ut:-512C>T(human) |
RGD |
PMID:15601967 |
RGD:1601218 |
NCBI chr19:49,186,034...49,188,736
Ensembl chr19:49,185,662...49,188,737
|
|
G |
Foxo3 |
forkhead box O3 |
|
IEP ISO |
protein:increased expression:myocardium: CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23954404 PMID:16467659 |
RGD:10402201 |
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Ftl1 |
ferritin light chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
|
|
G |
Fto |
FTO, alpha-ketoglutarate dependent dioxygenase |
severity |
ISO IEP |
CTD Direct Evidence: marker/mechanism DNA:SNP:intron:rs9939609 (human) DNA:SNP: :rs9939609 (human) DNA:SNP:intron:rs17817449 (human) DNA:SNPs: :rs9939609, rs1421085, rs17817449 (human) DNA:SNP: :rs3751812 (human) mRNA:increased expression:pancreas mRNA, protein:increased expression:liver |
CTD RGD |
PMID:17496892 PMID:19079260 PMID:19079261 PMID:19151714 PMID:19918250 PMID:21076408 PMID:23134754 PMID:23111453 PMID:31801409 PMID:21919686 PMID:29540276 PMID:25606423 PMID:32420297 PMID:35945320 More...
|
RGD:329812007, RGD:329812010, RGD:329812016, RGD:329812040, RGD:329845887, RGD:329901774, RGD:329951013, RGD:329951016 |
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
|
|
G |
Fxn |
frataxin |
|
ISO |
DNA:deletion:exon (mouse) |
RGD |
PMID:17404227 |
RGD:2307045 |
NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
ISO IEP |
mRNA, protein:increased expression:white fat associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:liver |
RGD |
PMID:15923630 PMID:19230846 |
RGD:2307347, RGD:2307340 |
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gabra6 |
gamma-aminobutyric acid type A receptor subunit alpha6 |
|
IAGP |
DNA:polymorphism:3' utr:1519T>C, abdominal obesity and hypercortisolism |
RGD |
PMID:12080446 |
RGD:1626491 |
NCBI chr10:26,810,411...26,825,768
Ensembl chr10:26,810,423...26,825,769
|
|
G |
Gal |
galanin and GMAP prepropeptide |
no_association |
ISO |
protein:increased expression:plasma |
RGD |
PMID:15930442 PMID:11220530 |
RGD:1625748, RGD:1624334 |
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Galp |
galanin-like peptide |
|
IEP |
mRNA:decreased expression:arcuate nucleus |
RGD |
PMID:15256810 |
RGD:2313739 |
NCBI chr 1:67,684,023...67,703,121
Ensembl chr 1:67,684,025...67,702,269
|
|
G |
Galr1 |
galanin receptor 1 |
no_association |
ISO |
|
RGD |
PMID:15930442 |
RGD:1625748 |
NCBI chr18:75,772,021...75,787,577
Ensembl chr18:75,772,023...75,787,577
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:27987997 |
RGD:13792668 |
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gas7 |
growth arrest specific 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19270708 |
|
NCBI chr10:52,152,718...52,383,283
Ensembl chr10:52,152,493...52,383,276
|
|
G |
Gcg |
glucagon |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20065960 |
|
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
|
|
G |
Gck |
glucokinase |
|
IDA |
DNA, mRNA, protein:hypermethylation, increased expression:liver |
RGD |
PMID:21239437 |
RGD:7488967 |
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gckr |
glucokinase regulator |
no_association |
ISO |
|
RGD |
PMID:12739015 |
RGD:1626607 |
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
|
|
G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20882379 PMID:11118009 |
RGD:1625423 |
NCBI chr 4:119,496,691...119,546,472
Ensembl chr 4:119,496,714...119,546,471
|
|
G |
Gh1 |
growth hormone 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8923850 |
|
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
susceptibility |
ISO |
ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, age at onset of CTD Direct Evidence: marker/mechanism DNA:SNP:intron (rs35683) (human) |
ClinVar OMIM CTD RGD |
PMID:11502844 PMID:12050239 PMID:12161552 PMID:16204371 PMID:25741868 PMID:23900445 More...
|
RGD:405650675 |
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
|
ISO |
DNA:point mutation:exon:F279L |
RGD |
PMID:16511600 |
RGD:1625270 |
NCBI chr 2:110,268,489...110,271,865
Ensembl chr 2:110,268,489...110,271,865
|
|
G |
Gip |
gastric inhibitory polypeptide |
|
ISO IEP |
protein:increased expression:plasma (rat) associated with Polycystic Ovary Syndrome; protein:increased expression:plasma (human) |
RGD |
PMID:3546047 PMID:18063845 PMID:19375579 |
RGD:2312551, RGD:2312547, RGD:2312588 |
NCBI chr10:80,968,360...80,976,506
Ensembl chr10:80,968,352...80,976,503
|
|
G |
Gipr |
gastric inhibitory polypeptide receptor |
susceptibility |
ISO |
DNA:polymorphism:intron 1 C>A (rs2302382) (human) mRNA:splice variant:pancreatic islet (mouse) mRNA:reduced expression:fat tissue (human) |
RGD |
PMID:12068290 PMID:19254363 PMID:17971513 PMID:17395281 |
RGD:737714, RGD:2312615, RGD:2312612, RGD:2312616 |
NCBI chr 1:78,804,287...78,814,462
Ensembl chr 1:78,805,593...78,814,462
|
|
G |
Gja5 |
gap junction protein, alpha 5 |
|
IEP |
mRNA, protein:decreased expression:mesenteric artery |
RGD |
PMID:18324386 |
RGD:7207466 |
NCBI chr 2:184,602,407...184,621,952
Ensembl chr 2:184,564,475...184,621,952
|
|
G |
Gldc |
glycine decarboxylase |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:10873393 PMID:11286506 PMID:12126939 PMID:15670722 PMID:15791207 PMID:17361008 PMID:20301531 PMID:25741868 PMID:26179960 PMID:27362913 PMID:28492532 More...
|
|
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
|
|
G |
Glp1r |
glucagon-like peptide 1 receptor |
|
IEP ISO |
mRNA:decreased expression:hypothalamus medial zone DNA:SNP:intron (rs2268641) (human) |
RGD |
PMID:15279492 PMID:23900445 |
RGD:1624351, RGD:405650675 |
NCBI chr20:8,972,004...9,010,241
Ensembl chr20:8,972,004...9,010,241
|
|
G |
Glrx |
glutaredoxin |
|
IEP |
protein:increased expression:renal visceral adipose: |
RGD |
PMID:23404913 |
RGD:9686064 |
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Glul |
glutamate-ammonia ligase |
|
IDA ISO |
protein:increased activity:skeletal muscle:activity is increased in Zucker fa/fa genetically obese but not dietary obese (fa/?) rats vs non-obese (fa/?) rats CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20882379 PMID:15481771 |
RGD:2301479 |
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Gnas |
GNAS complex locus |
|
ISO |
CTD Direct Evidence: marker/mechanism associated with Polycystic Ovary Syndrome;DNA:polymorphism: :393T>C (human) ClinVar Annotator: match by term: Obesity |
CTD ClinVar RGD |
PMID:11784876 PMID:12970262 PMID:17062894 PMID:21525160 PMID:23281139 PMID:23796510 PMID:25741868 PMID:25802881 PMID:28492532 PMID:29059381 PMID:17062894 More...
|
RGD:11568045 |
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gnb3 |
G protein subunit beta 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15961981 PMID:16141801 |
|
NCBI chr 4:157,639,468...157,645,171
Ensembl chr 4:157,639,469...157,645,173
|
|
G |
Gnpda2 |
glucosamine-6-phosphate deaminase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19079261 |
|
NCBI chr14:38,520,663...38,538,713
Ensembl chr14:38,520,705...38,538,713
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
|
IEP |
protein:increased expression:skeletal muscle tissue, T-tubule (rat) |
RGD |
PMID:23743348 |
RGD:11041118 |
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
|
|
G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
IEP |
mRNA:increased expression:pancreatic islet |
RGD |
PMID:9032096 |
RGD:2313659 |
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
|
|
G |
Gpr12 |
G protein-coupled receptor 12 |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr12:8,522,709...8,525,875
Ensembl chr12:8,522,953...8,527,973
|
|
G |
Gpr17 |
G protein-coupled receptor 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34144038 |
|
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
|
ISO |
protein:increased expression, activity:liver: |
RGD |
PMID:25865565 |
RGD:11342811 |
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15184668 PMID:30298849 |
RGD:401960083 |
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
treatment |
IEP ISO |
mRNA:decreased expression:adipose tissue (rat) protein:decreased expression, activity:plasma (mouse) CTD Direct Evidence: marker/mechanism mRNA:decreased expression:embryo, blastocyst protein:decreased expression:plasma |
CTD RGD |
PMID:11328671 PMID:19270708 PMID:19212806 PMID:18562625 PMID:21862610 PMID:31791316 PMID:21535898 More...
|
RGD:2307430, RGD:2312633, RGD:5683906, RGD:401827913, RGD:401827923 |
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gria4 |
glutamate ionotropic receptor AMPA type subunit 4 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr 8:1,562,118...2,035,035
Ensembl chr 8:1,562,119...2,034,979
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
ISO |
mRNA:decreased expression:gonadal fat pad (mouse) |
RGD |
PMID:20150287 |
RGD:5687771 |
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
IEP |
mRNA:decreased expression:liver |
RGD |
PMID:31063713 |
RGD:14701042 |
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gucy2c |
guanylate cyclase 2C |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr 4:169,568,505...169,649,092
Ensembl chr 4:169,568,529...169,649,092
|
|
G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
|
IEP ISO |
protein:increased expression:skeletal muscle CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20882379 PMID:16088331 |
RGD:2302228 |
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
|
|
G |
Hcrt |
hypocretin neuropeptide precursor |
|
IEP ISO |
mRNA:increased expression:perifornical nucleus CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:27071101 PMID:12560202 |
RGD:1358428 |
NCBI chr10:85,689,979...85,691,214
Ensembl chr10:85,689,465...85,691,210
|
|
G |
Hdac4 |
histone deacetylase 4 |
|
ISO |
mRNA,protein:decreased expression:mononuclear cell, adipose tissue: |
RGD |
PMID:24086512 |
RGD:9681453 |
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
|
|
G |
Hfe |
homeostatic iron regulator |
|
ISO |
associated with Diabetes Mellitus, Type 2;DNA:missense mutations:CDS:p.C282Y, p.H63D (human) |
RGD |
PMID:10705106 |
RGD:1601449 |
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:12706940 |
RGD:1642704 |
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
associated with hepatocellular carcinoma;RNA:decreased expression:liver: |
RGD |
PMID:31321740 |
RGD:155882550 |
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hk1 |
hexokinase 1 |
susceptibility |
IDA ISO |
|
RGD |
PMID:12524468 PMID:131232 |
RGD:1601528, RGD:1601527 |
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
|
|
G |
Hk2 |
hexokinase 2 |
|
ISO IEP |
mRNA:increased expression:gastrocnemius CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20882379 PMID:11319725 PMID:16555472 |
RGD:2313227, RGD:1624365 |
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmga2 |
high mobility group AT-hook 2 |
|
ISO |
|
RGD |
PMID:10742101 |
RGD:1601569 |
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
|
|
G |
Hmgb2 |
high mobility group box 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
|
IEP |
protein:decreased activity:liver (rat) |
RGD |
PMID:1685984 |
RGD:2326155 |
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18334666 PMID:18375438 PMID:19171794 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hoxb5 |
homeo box B5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22484627 |
|
NCBI chr10:81,269,372...81,271,580
Ensembl chr10:81,269,372...81,271,580
|
|
G |
Hp |
haptoglobin |
treatment |
ISO IEP IDA |
protein:increased expression:serum mRNA:increased expression:white fat |
RGD |
PMID:15181041 PMID:11807829 PMID:17161237 PMID:19917068 |
RGD:1626346, RGD:1626349, RGD:1626339, RGD:9685197 |
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hrh3 |
histamine receptor H3 |
|
IDA |
|
RGD |
PMID:17189541 |
RGD:1626405 |
NCBI chr 3:167,191,551...167,196,642
Ensembl chr 3:167,191,558...167,196,642
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17628001 PMID:21786805 PMID:15131764 PMID:16914598 PMID:15118671 |
RGD:1625073, RGD:1625071, RGD:1331525 |
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
resistance |
ISO IEP |
from transgenic mice expressing human HSD11B2 mRNA:increased expression:adipose tissue:subcutaneous not retroperitoneal fat |
RGD |
PMID:15793240 PMID:17208436 |
RGD:1625083, RGD:1625081 |
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
|
ISO |
DNA:SNP:CDS:homozygous P2/P2 allele at position 1267 (p<0.000001) |
RGD |
PMID:11319647 |
RGD:1626642 |
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26655953 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Htr1b |
5-hydroxytryptamine receptor 1B |
|
IEP |
protein:increase expression:arcuate nucleus |
RGD |
PMID:10564740 |
RGD:1626450 |
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
susceptibility no_association |
ISO |
DNA:polymorphism:promoter:-1438G>A CTD Direct Evidence: marker/mechanism DNA:SNP:intron (rs912127) (human) |
CTD RGD |
PMID:16491645 PMID:17097612 PMID:16328014 PMID:16491645 PMID:23900445 |
RGD:1624369, RGD:1624370, RGD:1624369, RGD:405650675 |
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
|
|
G |
Htr2c |
5-hydroxytryptamine receptor 2C |
susceptibility |
ISO |
DNA:polymorphism:promoter:-759C>T associated with Schizophrenia and Psychotic Disorders;DNA:polymorphisms:promoter:multiple CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17702092 PMID:19142110 PMID:15048662 PMID:17016522 |
RGD:1624991, RGD:1624982 |
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO IEP |
protein:increased secretion:plasma (human) protein:increased expression:submandibular gland (rat) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11782876 PMID:20004360 PMID:20973827 |
RGD:4145463, RGD:4145329 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
|
RGD |
PMID:14969338 |
RGD:1626475 |
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27020609 |
|
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ifng |
interferon gamma |
|
IEP |
associated with Asthma;protein:increased expression:serum |
RGD |
PMID:19575934 |
RGD:2311494 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
IEP |
mRNA:decreased expression:heart (rat) |
RGD |
PMID:11009458 |
RGD:12904882 |
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11528401 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:22537059 PMID:17259371 PMID:17426323 |
RGD:1626479, RGD:1626478 |
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
IEP |
mRNA, protein:decreased expression:pancreatic fat pad |
RGD |
PMID:22067319 |
RGD:10402755 |
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
|
ISO |
human transgene overexpressed in mouse brain |
RGD |
PMID:15889232 |
RGD:2301717 |
NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:15685173 |
RGD:10045952 |
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
|
IEP ISO |
protein:increase expression:serum |
RGD |
PMID:18787467 PMID:28843383 |
RGD:2308945, RGD:14975146 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il15 |
interleukin 15 |
|
ISO |
mRNA, protein:altered expression:skeletal muscle, plasma |
RGD |
PMID:18697873 |
RGD:2313573 |
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il18 |
interleukin 18 |
treatment |
IEP ISO |
|
RGD |
PMID:20490358 PMID:16732281 |
RGD:7175343, RGD:14695532 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
ISO IEP |
protein:increased expression:plasma (mouse) protein:increased expression:kidney (rat) |
RGD |
PMID:16567518 PMID:23150506 PMID:20490358 PMID:24146106 PMID:28843383 |
RGD:1626637, RGD:7175086, RGD:7175343, RGD:10450599, RGD:14975146 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
mRNA, protein:increased expression:adipose tissue |
RGD |
PMID:12975454 PMID:12716739 |
RGD:1626664, RGD:1626665 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il3 |
interleukin 3 |
|
ISO |
protein: decreased expression: plasma |
RGD |
PMID:21203453 |
RGD:5686875 |
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
|
|
G |
Il6 |
interleukin 6 |
|
ISO IEP |
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased expression:extracellular space (human) mRNA:increased expression:islet of Langerhans CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20141834 PMID:24042701 PMID:16493118 PMID:19228869 PMID:21826222 |
RGD:1601582, RGD:2307257, RGD:10402828 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
susceptibility |
ISO |
DNA:duplication protein:increased expression:serum DNA:polymorphism: :p.D358A DNA:SNP, haplotypes:promoter:-208G>A (rs4845617) (human) |
RGD |
PMID:12917504 PMID:17434052 PMID:16817825 PMID:17984249 |
RGD:1625428, RGD:1625429, RGD:1625430, RGD:10402807 |
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Il7 |
interleukin 7 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20376352 |
|
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
|
|
G |
Inpp5e |
inositol polyphosphate-5-phosphatase E |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:skeletal muscle, white adipose tissue |
CTD RGD |
PMID:19668215 PMID:23349329 PMID:23349329 |
RGD:12911211, RGD:12911211 |
NCBI chr 3:9,216,776...9,229,539
Ensembl chr 3:9,216,776...9,229,450
|
|
G |
Inppl1 |
inositol polyphosphate phosphatase-like 1 |
|
ISO |
DNA:SNPs: :rs2276047,snp8,rs9886(human) |
RGD |
PMID:15220217 |
RGD:1626127 |
NCBI chr 1:156,183,043...156,197,500
Ensembl chr 1:156,183,059...156,197,500
|
|
G |
Ins2 |
insulin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:2777199 PMID:8923850 PMID:11528401 PMID:29035695 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Irs1 |
insulin receptor substrate 1 |
|
IDA ISO |
protein:decreased tyrosine phosphorylation, increased serine phosphorylation:skeletal muscle CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23954404 PMID:22982470 |
RGD:7207062 |
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Irs2 |
insulin receptor substrate 2 |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
|
|
G |
Itgam |
integrin subunit alpha M |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:monocyte (human) |
CTD RGD |
PMID:29035695 PMID:21446916 |
RGD:329901665 |
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
|
IEP |
|
RGD |
PMID:22134356 |
RGD:11352709 |
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO IEP |
protein:decreased expression:hypothalamus |
RGD |
PMID:14630696 PMID:23397595 |
RGD:1627661, RGD:10411893 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
mRNA,protein:increased expression:heart |
RGD |
PMID:30629164 |
RGD:401900736 |
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:7889573 PMID:9024139 PMID:9927399 PMID:10753933 PMID:10973849 PMID:11113008 PMID:11468227 PMID:11668638 PMID:11854117 PMID:12354768 PMID:15051636 PMID:15840476 PMID:16432067 PMID:17160940 PMID:17445409 PMID:18441445 PMID:18593567 PMID:19716085 PMID:19841300 PMID:22581653 PMID:22949429 PMID:23303164 PMID:24606995 PMID:24623279 PMID:24667783 PMID:25741868 PMID:26847485 PMID:28492532 PMID:29672598 PMID:30246897 More...
|
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Kcnma1 |
potassium calcium-activated channel subfamily M alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27605626 |
|
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
|
|
G |
Kctd15 |
potassium channel tetramerization domain containing 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19079261 |
|
NCBI chr 1:87,258,658...87,271,979
Ensembl chr 1:87,258,658...87,273,497
|
|
G |
Kdm3a |
lysine demethylase 3A |
|
ISO ISS |
OMIM:601665 |
MouseDO RGD |
PMID:19875498 |
RGD:9590220 |
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
|
|
G |
Kif4a |
kinesin family member 4A |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr X:65,721,746...65,824,277
Ensembl chr X:65,721,779...65,824,139
|
|
G |
Kitlg |
KIT ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23954404 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Lactb |
lactamase, beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18344982 |
|
NCBI chr 8:67,571,504...67,587,592
Ensembl chr 8:67,571,500...67,587,539
|
|
G |
Lbp |
lipopolysaccharide binding protein |
treatment |
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23349936 PMID:19917068 |
RGD:9685197 |
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
|
|
G |
Lcn2 |
lipocalin 2 |
|
IEP ISO |
mRNA:increased expression:epididymal fat pad, adipose cell (rat) mRNA:decreased expression:ovary, testicle protein:increased expression:serum |
RGD |
PMID:18292240 PMID:32627017 PMID:21143924 |
RGD:2316514, RGD:126790490, RGD:126790530 |
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25554529 PMID:15118671 |
RGD:1331525 |
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lep |
leptin |
no_association treatment |
IEP IMP ISO IDA ISS |
protein:increased expression:serum mouse protein in a rat model DNA:nonsense mutation:cds: ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: SIM1-related condition OMIM:601665 CTD Direct Evidence: marker/mechanism|therapeutic |
ClinVar MouseDO CTD RGD |
PMID:9202122 PMID:9502777 PMID:9826672 PMID:17517446 PMID:18515891 PMID:19913045 PMID:20122948 PMID:24042701 PMID:25086370 PMID:25551525 PMID:25554529 PMID:25741868 PMID:26186301 PMID:27071101 PMID:28492532 PMID:28698385 PMID:31313498 PMID:21075806 PMID:19726711 PMID:19267279 PMID:15910756 PMID:15118671 PMID:7624776 PMID:10029567 PMID:23793169 PMID:23800849 PMID:22948215 More...
|
RGD:5128551, RGD:5128629, RGD:2311132, RGD:1643130, RGD:1331525, RGD:2311134, RGD:10053612, RGD:10053638, RGD:8549777, RGD:12904911 |
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lepem1Sage |
leptin; zinc finger nuclease induced mutant1, Sage |
|
IMP |
|
RGD |
PMID:22948215 |
RGD:12904911 |
|
|
G |
Lepm1Kyo |
leptin; ENU induced mutant1, Kyo |
|
IMP |
|
RGD |
PMID:23800849 |
RGD:8549777 |
|
|
G |
Lepr |
leptin receptor |
susceptibility treatment no_association sexual_dimorphism disease_progression |
ISO IAGP IMP ISS |
mRNA:decreased expression:lung DNA:polymorphism:exon:p.Q223R (human) DNA:missense mutation:CDS:p.Q269P (rat) protein:increased expression:hippocampus,astrocyte: compared to age-matched lean +/fa rats compared to heterozygous controls +/fa compared to BN ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity disorder CTD Direct Evidence: marker/mechanism OMIM:601665 DNA:mutations:cds: : (rat) DNA:mutations::cds: : (rat) |
ClinVar CTD MouseDO RGD |
PMID:3519326 PMID:8666155 PMID:11354636 PMID:11380591 PMID:11443193 PMID:12006639 PMID:17065336 PMID:17229951 PMID:17785359 PMID:18490929 PMID:19913045 PMID:20567778 PMID:21393862 PMID:21744741 PMID:22276206 PMID:22331430 PMID:23563609 PMID:24263156 PMID:25222487 PMID:25741868 PMID:26467025 PMID:28492532 PMID:29743445 PMID:30689673 PMID:30993381 PMID:35235096 PMID:35472412 PMID:20592105 PMID:8841178 PMID:18204169 PMID:8702432 PMID:15118671 PMID:24785100 PMID:16284652 PMID:9545018 PMID:22693203 PMID:27465994 PMID:9843879 PMID:11500530 PMID:20159938 PMID:27225180 PMID:27465994 PMID:33568522 PMID:32710530 PMID:28746409 PMID:10901178 More...
|
RGD:5129154, RGD:1600612, RGD:5128855, RGD:729297, RGD:1331525, RGD:10411891, RGD:10412018, RGD:10412023, RGD:10412038, RGD:12911217, RGD:628910, RGD:628581, RGD:7365117, RGD:12910507, RGD:12911217, RGD:401965412, RGD:401960103, RGD:401965413, RGD:401965414 |
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Leprem2 |
leptin receptor; TALEN induced mutant 2 |
|
IMP |
|
RGD |
PMID:27225180 |
RGD:12910507 |
|
|
G |
Leprem2Mcwi |
leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin |
disease_progression |
IMP |
|
RGD |
PMID:27465994 PMID:27465994 |
RGD:12911217, RGD:12911217 |
|
|
G |
Leprem3 |
leptin receptor; TALEN induced mutant 3 |
|
IMP |
|
RGD |
PMID:27225180 |
RGD:12910507 |
|
|
G |
Leprfa |
leptin receptor; fa mutant |
sexual_dimorphism |
IAGP |
compared to BN compared to heterozygous controls +/fa compared to age-matched lean +/fa rats |
RGD |
PMID:20159938 PMID:11500530 PMID:9843879 |
RGD:7365117, RGD:628581, RGD:628910 |
|
|
G |
Leprot |
leptin receptor overlapping transcript |
|
ISO |
ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 5:116,289,843...116,301,951
Ensembl chr 5:116,289,822...116,301,988
|
|
G |
Lipc |
lipase C, hepatic type |
|
ISO IAGP |
associated with Diabetes Mellitus, Insulin-Dependent; protein:increased expression:plasma (human) protein:altered expression:liver, plasma (rat) |
RGD |
PMID:12843191 PMID:11544558 |
RGD:2308835, RGD:2308784 |
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lipe |
lipase E, hormone sensitive type |
|
IEP |
mRNA:decreased expression:white fat |
RGD |
PMID:17712951 |
RGD:2313580 |
NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:80,965,627...80,984,310
|
|
G |
Lipg |
lipase G, endothelial type |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:16772345 |
RGD:1641819 |
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
G |
Lpl |
lipoprotein lipase |
treatment |
IEP ISO IDA |
mRNA:increased expression:white fat CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18344982 PMID:17712951 PMID:18952837 PMID:28514832 PMID:27160499 |
RGD:2313580, RGD:2313300, RGD:13793401, RGD:13794378 |
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
|
ISO |
protein:increased phosphorylation:endometrium (human) |
RGD |
PMID:20074784 |
RGD:13782055 |
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
|
ISO |
protein:increased phosphorylation:endometrium (human) |
RGD |
PMID:20074784 |
RGD:13782055 |
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapt |
microtubule-associated protein tau |
|
IDA |
|
RGD |
PMID:25257559 |
RGD:13800921 |
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mbl1 |
mannose binding lectin 1 |
|
ISO |
protein:decreased secretion:plasma (mouse) |
RGD |
PMID:16955210 |
RGD:4889156 |
NCBI chr16:17,029,146...17,035,187
Ensembl chr16:17,029,118...17,035,174
|
|
G |
Mbl2 |
mannose binding lectin 2 |
|
ISO |
DNA:missense mutations:cds:p.R52C, p.G57E (human) |
RGD |
PMID:16955210 |
RGD:4889156 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Mc3r |
melanocortin 3 receptor |
susceptibility |
ISO ISS |
DNA:point mutation:I183N DNA:missense mutations:cds:p.T6K, p.V81I (human) OMIM:601665 ClinVar Annotator: match by term: Obesity |
MouseDO ClinVar RGD |
PMID:11889220 PMID:15118671 PMID:16123355 |
RGD:1625178, RGD:1331525, RGD:6484587 |
NCBI chr 3:161,016,347...161,017,444
Ensembl chr 3:161,016,347...161,017,444
|
|
G |
Mc4r |
melanocortin 4 receptor |
|
ISO IMP IEP ISS |
DNA:nonsense mutation:cds:p.K314X (rat) mRNA:decreased expression:hypothalamus (rat) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, autosomal dominant ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, autosomal dominant OMIM:601665 mRNA, protein:decreased expression:liver (rat) ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, autosomal dominant | ClinVar Annotator: match by term: SIM1-related condition ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: NR0B2-related condition | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity due to melanocortin 4 receptor deficiency | ClinVar Annotator: match by term: Obesity, autosomal dominant |
CTD ClinVar MouseDO RGD |
PMID:9267995 PMID:10078568 PMID:10199800 PMID:10577903 PMID:10585465 PMID:10592235 PMID:10903341 PMID:10903343 PMID:11443223 PMID:12364414 PMID:12364415 PMID:12499395 PMID:12588803 PMID:12629567 PMID:12646665 PMID:12646666 PMID:12690102 PMID:12815165 PMID:12851297 PMID:12959994 PMID:12970296 PMID:14633862 PMID:14764812 PMID:14764818 PMID:14973783 PMID:15037865 PMID:15126516 PMID:15448103 PMID:15466016 PMID:15486053 PMID:15585384 PMID:15805150 PMID:15975705 PMID:16030156 PMID:16032553 PMID:16083993 PMID:16094248 PMID:16231025 PMID:16274851 PMID:16289450 PMID:16469222 PMID:16492696 PMID:16507637 PMID:16611215 PMID:16614075 PMID:16616374 PMID:16710097 PMID:16752916 PMID:16960181 PMID:17143585 PMID:17185898 PMID:17286227 PMID:17306938 PMID:17357083 PMID:17492953 PMID:17517246 PMID:17519222 PMID:17579204 PMID:17590021 PMID:17628007 PMID:17668051 PMID:17986382 PMID:18454148 PMID:18559663 PMID:18801902 PMID:18835933 PMID:18997677 PMID:19011902 PMID:19079260 PMID:19079261 PMID:19091795 PMID:19151714 PMID:19179454 PMID:19184404 PMID:19244934 PMID:19284607 PMID:19298524 PMID:19301229 PMID:19400288 PMID:19417090 PMID:19766264 PMID:19889825 PMID:20462274 PMID:20631012 PMID:20696697 PMID:20826565 PMID:20966905 PMID:20975296 PMID:21085626 PMID:21404042 PMID:22106157 PMID:22447289 PMID:22463805 PMID:22688572 PMID:23146882 PMID:23251400 PMID:23505181 PMID:23791567 PMID:24248383 PMID:24276017 PMID:24385306 PMID:24426828 PMID:24512492 PMID:24611737 PMID:24705671 PMID:24780838 PMID:24890885 PMID:25076858 PMID:25136332 PMID:25332687 PMID:25741868 PMID:25741869 PMID:26047380 PMID:26179253 PMID:26238496 PMID:26244670 PMID:26467025 PMID:26588347 PMID:26666384 PMID:26782456 PMID:26788538 PMID:27222505 PMID:27654141 PMID:28166811 PMID:28218067 PMID:28492532 PMID:29273807 PMID:29311635 PMID:29758564 PMID:29861388 PMID:29970488 PMID:30048591 PMID:30719650 PMID:30811542 PMID:30926952 PMID:30991789 PMID:31002796 PMID:31118516 PMID:31841602 PMID:32185475 PMID:32534219 PMID:32952152 PMID:32971154 PMID:33761344 PMID:33889637 PMID:12646665 PMID:15118671 PMID:21527895 PMID:9019399 PMID:21779089 PMID:24400148 PMID:35945320 More...
|
RGD:1600756, RGD:1331525, RGD:6478803, RGD:6484144, RGD:6484210, RGD:13825242, RGD:329951016 |
NCBI chr18:60,419,832...60,421,719
Ensembl chr18:60,419,832...60,421,719
|
|
G |
Mc4rm1Hubr |
melanocortin 4 receptor; ENU induced mutation 1, Hubr |
|
IMP |
DNA:nonsense mutation:cds:p.K314X |
RGD |
PMID:21527895 PMID:24400148 |
RGD:6478803, RGD:13825242 |
|
|
G |
Mchr1 |
melanin-concentrating hormone receptor 1 |
|
IEP |
mRNA:increased expression:hypothalamus |
RGD |
PMID:15363890 |
RGD:1624360 |
NCBI chr 7:112,761,554...112,764,746
Ensembl chr 7:112,761,554...112,764,032
|
|
G |
Me1 |
malic enzyme 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19270708 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mfn2 |
mitofusin 2 |
|
ISO IEP |
mRNA:decreased expression:skeletal muscle tissue (human) mRNA:decreased expression:liver (rat) |
RGD |
PMID:12598526 PMID:25336449 |
RGD:1601412, RGD:12880438 |
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mgrn1 |
mahogunin ring finger 1 |
|
ISO |
|
RGD |
PMID:16638826 |
RGD:1641947 |
NCBI chr10:10,638,881...10,688,332
Ensembl chr10:10,638,880...10,688,315
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
ISO |
DNA:polymorphisms:promoter mRNA, protein:increased expression:mononuclear cell, plasma |
RGD |
PMID:16247506 PMID:15472203 |
RGD:1641950, RGD:1641953 |
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Mir107 |
microRNA 107 |
|
ISO |
RNA:decreased expression:liver: |
RGD |
PMID:21120623 |
RGD:14975298 |
NCBI chr 1:232,337,767...232,337,853
Ensembl chr 1:232,337,767...232,337,853
|
|
G |
Mir125a |
microRNA 125a |
|
ISO |
|
RGD |
PMID:31988048 |
RGD:21403676 |
NCBI chr 1:58,677,626...58,677,710
Ensembl chr 1:58,677,626...58,677,710
|
|
G |
Mir130a |
microRNA 130a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28242765 |
|
NCBI chr 3:69,822,542...69,822,629
Ensembl chr 3:69,822,542...69,822,629
|
|
G |
Mir130b |
microRNA 130b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28242765 |
|
NCBI chr11:83,880,163...83,880,244
Ensembl chr11:83,880,163...83,880,244
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
miRNA:decreased expression:serum |
RGD |
PMID:28970282 PMID:27856635 PMID:29479888 |
RGD:21079445, RGD:21079446, RGD:24922220 |
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir184 |
microRNA 184 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23954404 |
|
NCBI chr 8:90,343,134...90,343,210
Ensembl chr 8:90,343,134...90,343,210
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23954404 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir223 |
microRNA 223 |
|
ISO |
RNA:increased expression:pancreatic islet |
RGD |
PMID:31118273 |
RGD:25823139 |
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
|
|
G |
Mir23a |
microRNA 23a |
|
ISO |
associated with hepatocellular carcinoma;RNA:increased expression:exosome, liver: |
RGD |
PMID:31321740 |
RGD:155882550 |
NCBI chr19:23,954,997...23,955,071
Ensembl chr19:23,954,997...23,955,071
|
|
G |
Mir23b |
microRNA 23b |
|
ISO |
associated with hepatocellular carcinoma;RNA:increased expression:exosome, liver: |
RGD |
PMID:31321740 |
RGD:155882550 |
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
|
|
G |
Mir34a |
microRNA 34a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23834033 |
|
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
|
|
G |
Mkks |
MKKS centrosomal shuttling protein |
no_association |
ISO ISS |
OMIM:601665 |
MouseDO RGD |
PMID:15483080 PMID:10973251 |
RGD:1601414, RGD:1581208 |
NCBI chr 3:124,201,877...124,221,142
Ensembl chr 3:124,201,877...124,220,162
|
|
G |
Mmp19 |
matrix metallopeptidase 19 |
|
ISO |
mRNA:increased expression:adipose tissue |
RGD |
PMID:15169894 PMID:12529376 |
RGD:1642022, RGD:1642023 |
NCBI chr 7:1,221,229...1,229,555
Ensembl chr 7:1,221,343...1,229,555
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21156398 PMID:17512313 |
RGD:1642026 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mmut |
methylmalonyl-CoA mutase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 9:19,928,720...19,956,985
Ensembl chr 9:19,928,727...19,957,046
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29035695 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
|
|
G |
Mt-cyb |
mitochondrially encoded cytochrome b |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:12905068 PMID:25741868 |
|
NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
|
|
G |
Mt-nd1 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 |
|
ISO |
DNA:missense mutation: :p.A64V (human) |
RGD |
PMID:16060290 |
RGD:2300401 |
NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
|
|
G |
Mt3 |
metallothionein 3 |
|
ISO |
|
RGD |
PMID:21726645 |
RGD:6480475 |
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Mtch2 |
mitochondrial carrier 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19079261 |
|
NCBI chr 3:76,830,549...76,850,189
Ensembl chr 3:76,830,413...76,850,189
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
IEP |
mRNA, protein:decreased expression:hypothalamus |
RGD |
PMID:25807795 |
RGD:11570513 |
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
susceptibility |
ISO |
DNA:polymorphisms |
RGD |
PMID:15635487 PMID:15635487 |
RGD:1625486, RGD:1625486 |
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
IEP |
mRNA:decreased expression:pancreas (rat) |
RGD |
PMID:22421529 |
RGD:7240547 |
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myh10 |
myosin heavy chain 10 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr10:53,393,901...53,525,174
Ensembl chr10:53,394,389...53,525,165
|
|
G |
Myh9 |
myosin, heavy chain 9 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 PMID:31064749 |
|
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
|
|
G |
Myod1 |
myogenic differentiation 1 |
|
IEP |
mRNA:decreased expression:plantaris |
RGD |
PMID:22349736 PMID:18508911 |
RGD:9686079, RGD:2313320 |
NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:96,884,948...96,887,554
|
|
G |
Myog |
myogenin |
|
IEP |
mRNA:decreased expression:plantaris |
RGD |
PMID:18508911 |
RGD:2313320 |
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23834033 PMID:17618961 |
RGD:1642336 |
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
IEP |
protein:increased expression:artery |
RGD |
PMID:17515452 |
RGD:2314435 |
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
|
|
G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
|
|
G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
ISO |
|
RGD |
PMID:14557830 |
RGD:1642050 |
NCBI chr 3:154,738,566...154,821,395
Ensembl chr 3:154,738,581...154,818,594
|
|
G |
Ndufb6 |
NADH:ubiquinone oxidoreductase subunit B6 |
|
IEP |
mRNA:decreased expression:epididymal fat pad |
RGD |
PMID:20559011 |
RGD:13822707 |
NCBI chr 5:55,400,543...55,410,110
Ensembl chr 5:55,400,543...55,410,181
|
|
G |
Negr1 |
neuronal growth regulator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19079261 |
|
NCBI chr 2:245,624,460...246,359,605
Ensembl chr 2:245,624,435...246,356,730
|
|
G |
Neil1 |
nei-like DNA glycosylase 1 |
|
ISO ISS |
CTD Direct Evidence: marker/mechanism OMIM:601665 |
CTD MouseDO |
PMID:16446448 PMID:21285402 |
|
NCBI chr 8:57,550,142...57,556,884
Ensembl chr 8:57,550,147...57,556,258
|
|
G |
Neurod1 |
neuronal differentiation 1 |
|
ISO |
mRNA:increased expression:pancreas |
RGD |
PMID:15979049 |
RGD:1625044 |
NCBI chr 3:64,359,554...64,363,526
Ensembl chr 3:64,359,395...64,363,649
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
protein:decreased expression:liver macrophage: protein:decreased expression:hepatocyte : |
RGD |
PMID:32102936 PMID:32102936 |
RGD:21201281, RGD:21201281 |
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nhlh2 |
nescient helix loop helix 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20808804 |
|
NCBI chr 2:189,444,287...189,449,625
Ensembl chr 2:189,442,711...189,449,625
|
|
G |
Nmb |
neuromedin B |
susceptibility |
ISO IEP |
protein:increased expression:central hypothalamus:concentrations higher in obese (fa/fa) than in lean (Fa/?) male Zucker rats, not affected by weight loss |
RGD |
PMID:15585758 PMID:1709601 PMID:11194934 |
RGD:1642059, RGD:1642063, RGD:1642062 |
NCBI chr 1:134,869,446...134,875,507
Ensembl chr 1:134,869,446...134,872,190
|
|
G |
Nmu |
neuromedin U |
susceptibility |
IDA ISO |
DNA:polymorphisms:cds:p.R165W,p.A19E |
RGD |
PMID:17706946 PMID:16984985 PMID:15448684 |
RGD:1642093, RGD:1642094, RGD:1642095 |
NCBI chr14:31,844,564...31,872,196
Ensembl chr14:31,844,728...31,872,192
|
|
G |
Nnt |
nicotinamide nucleotide transhydrogenase |
|
IEP |
protein:decreased expression:gastrocnemius, soleus |
RGD |
PMID:25761734 |
RGD:13513980 |
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
IEP |
|
RGD |
PMID:16316351 |
RGD:1642132 |
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:sputum protein:increased expression:liver, gastrocnemius muscle, adipose tissue (mouse) |
RGD |
PMID:18098375 PMID:21896669 |
RGD:4891935, RGD:5509059 |
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IEP |
protein:decreased expression:artery |
RGD |
PMID:17623751 PMID:29180887 |
RGD:2292133, RGD:13504728 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nox4 |
NADPH oxidase 4 |
treatment |
IEP |
|
RGD |
PMID:30298849 |
RGD:401960083 |
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Npc1 |
NPC intracellular cholesterol transporter 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19151714 |
|
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,379,482...3,425,049
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
associated with Heart Failure; |
RGD |
PMID:23566312 |
RGD:7247714 |
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nppb |
natriuretic peptide B |
treatment |
ISO IEP |
associated with Diabetes Mellitus, Type 2 mRNA:decreased expression:heart associated with hypoxia; protein:increased expression:blood serum (rat) |
RGD |
PMID:21959345 PMID:24009719 PMID:33310031 |
RGD:5685647, RGD:7327171, RGD:329955450 |
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Npy |
neuropeptide Y |
|
IEP |
mRNA, protein:increased expression:hypothalamus |
RGD |
PMID:17447163 |
RGD:10448938 |
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Npy1r |
neuropeptide Y receptor Y1 |
susceptibility |
ISO IEP ISS |
associated with Hyperinsulinemia mRNA:increased expression:hypothalamus CTD Direct Evidence: marker/mechanism OMIM:601665 |
CTD MouseDO RGD |
PMID:20975297 PMID:9861026 PMID:17447163 |
RGD:1642306, RGD:10448938 |
NCBI chr16:23,037,788...23,047,330
Ensembl chr16:23,037,789...23,046,759
|
|
G |
Npy2r |
neuropeptide Y receptor Y2 |
|
ISO IEP |
mRNA:increased expression:hypothalamus |
RGD |
PMID:17019604 PMID:17447163 |
RGD:1642379, RGD:10448938 |
NCBI chr 2:167,901,999...167,912,165
Ensembl chr 2:167,903,879...167,905,024
|
|
G |
Npy5r |
neuropeptide Y receptor Y5 |
susceptibility |
ISO IEP |
DNA:polymorphisms mRNA:increased expression:hypothalamus CTD Direct Evidence: marker/mechanism DNA:SNP:utr (Y5R1c52) (human) |
CTD RGD |
PMID:10849579 PMID:10849579 PMID:15118671 PMID:17447163 PMID:23900445 |
RGD:1625493, RGD:1331525, RGD:10448938, RGD:405650675 |
NCBI chr16:23,055,427...23,063,384
Ensembl chr16:23,055,427...23,063,382
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17405841 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
ISO |
ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: NR0B2-related condition | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, mild, early-onset CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD RGD |
PMID:11136233 PMID:20233523 PMID:25741868 PMID:28492532 PMID:33094510 PMID:11136233 More...
|
RGD:1600912 |
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
disease_progression |
ISO IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17108812 PMID:20939869 PMID:25612518 |
RGD:1626248, RGD:13506790, RGD:15045599 |
NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
disease_progression |
ISO IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17108812 PMID:25612518 |
RGD:1626248, RGD:15045599 |
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
disease_progression |
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:25612518 |
RGD:15045599 |
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20869355 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20869355 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
no_association |
IDA ISO |
associated with Depressive Disorder, Major;DNA:SNP:intron:IVS2+646C>G (human) |
RGD GAD |
PMID:20723946 PMID:16725041 PMID:15118671 PMID:18246526 |
RGD:4892206, RGD:1601498, RGD:1331525, RGD:7174717 |
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
treatment |
IEP |
|
RGD |
PMID:30298849 |
RGD:401960083 |
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
treatment |
IEP |
mRNA:decreased expression:left ventricle myocardium (rat) |
RGD |
PMID:33310031 |
RGD:329955450 |
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
|
|
G |
Nrxn1 |
neurexin 1 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr 6:3,177,788...4,323,848
Ensembl chr 6:3,177,897...4,322,710
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Obesity |
CTD ClinVar |
PMID:15494731 |
|
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Nucb2 |
nucleobindin 2 |
|
IEP |
protein:increased expression:adipose tissue: |
RGD |
PMID:22641054 |
RGD:9831187 |
NCBI chr 1:170,750,830...170,787,356
Ensembl chr 1:170,750,877...170,787,353
|
|
G |
Nudc |
nuclear distribution C, dynein complex regulator |
|
ISO |
ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, mild, early-onset ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: NR0B2-related condition | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, mild, early-onset |
ClinVar |
PMID:11136233 PMID:20233523 PMID:25741868 PMID:28492532 PMID:33094510 |
|
NCBI chr 5:145,758,006...145,771,390
Ensembl chr 5:145,758,002...145,771,425
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29709520 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
treatment |
IEP ISO IMP |
DNA, mRNA:hypermethylation, increased expression:promoter, hypothalamus DNA:hypermethylation:promoter, peripheral blood mononuclear cell |
RGD |
PMID:31258545 PMID:31258545 PMID:16876155 |
RGD:401827956, RGD:401827956, RGD:401842391 |
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
|
|
G |
Otc |
ornithine transcarbamylase |
|
IEP |
protein:increased activity:liver (rat) |
RGD |
PMID:1330956 |
RGD:4144087 |
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
|
|
G |
Oxct1 |
3-oxoacid CoA transferase 1 |
|
IEP |
mRNA:decreased expression:thalamus (rat) |
RGD |
PMID:19219059 |
RGD:2326191 |
NCBI chr 2:53,236,370...53,384,715
Ensembl chr 2:53,236,368...53,384,714
|
|
G |
Pacs1 |
phosphofurin acidic cluster sorting protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23563609 |
|
NCBI chr 1:202,437,503...202,569,473
Ensembl chr 1:202,437,505...202,569,473
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20561897 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pax8 |
paired box 8 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr 3:7,185,721...7,242,363
Ensembl chr 3:7,185,723...7,242,363
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
ISO ISS |
DNA:missense mutation:cds: p.G483R (human) CTD Direct Evidence: marker/mechanism OMIM:601665 ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Obesity |
CTD MouseDO ClinVar RGD |
PMID:18604207 PMID:25741868 PMID:28492532 PMID:9207799 PMID:15189116 |
RGD:1601274, RGD:1357925 |
NCBI chr 2:4,395,543...4,442,434
Ensembl chr 2:4,395,543...4,442,434
|
|
G |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
|
IAGP ISO |
protein:increased expression:brainstem |
RGD |
PMID:15012590 PMID:11680901 |
RGD:1642350, RGD:1642351 |
NCBI chr X:14,580,036...14,583,478
Ensembl chr X:14,580,038...14,583,566
|
|
G |
Pde3a |
phosphodiesterase 3A |
|
IEP |
mRNA:decreased expression:heart |
RGD |
PMID:9648839 |
RGD:2300415 |
NCBI chr 4:174,172,804...174,443,944
Ensembl chr 4:174,172,868...174,438,274
|
|
G |
Pde9a |
phosphodiesterase 9A |
treatment |
ISO |
|
RGD |
PMID:34618683 |
RGD:242170038 |
NCBI chr20:9,469,809...9,562,949
Ensembl chr20:9,469,848...9,562,948
|
|
G |
Pdp1 |
pyruvate dehydrogenase phosphatase catalytic subunit 1 |
|
ISO |
|
RGD |
PMID:15897476 |
RGD:1642637 |
NCBI chr 5:25,446,843...25,455,107
Ensembl chr 5:25,446,272...25,455,217
|
|
G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
ISO |
mRNA:increased expression:exocrine pancreas (human) |
RGD |
PMID:15979049 |
RGD:1625044 |
NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30585412 |
|
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
|
|
G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
|
|
G |
Pgf |
placental growth factor |
|
ISO |
associated with Pre-eclampsia;protein:increased expression:serum associated with pancreatic cancer;protein:increased expression:plasma (human) |
RGD |
PMID:16020476 PMID:16769024 PMID:26861455 |
RGD:1642385, RGD:1642384, RGD:14349030 |
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
|
|
G |
Pgr |
progesterone receptor |
|
ISO |
|
RGD |
PMID:14557830 |
RGD:1642050 |
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
ISO |
|
RGD |
PMID:21949398 |
RGD:6482700 |
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
IEP ISO |
protein:decreased expression:soleus protein:decreased tyrosine phosphorylation:skeletal muscle, liver |
RGD |
PMID:16123202 PMID:9399964 |
RGD:1625220, RGD:1625218 |
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Pklr |
pyruvate kinase L/R |
|
ISO |
mRNA, protein:decreased expression:liver |
RGD |
PMID:12958186 |
RGD:1625583 |
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
|
RGD |
PMID:12818410 |
RGD:2311677 |
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
|
ISO |
|
RGD |
PMID:21372607 |
RGD:6484121 |
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Plin1 |
perilipin 1 |
susceptibility |
ISO |
DNA:snp:intron:g.11482G>A (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15001633 PMID:11371650 PMID:15985482 |
RGD:737723, RGD:1581041 |
NCBI chr 1:133,664,294...133,676,854
Ensembl chr 1:133,664,892...133,676,828
|
|
G |
Plscr3 |
phospholipid scramblase 3 |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr10:54,566,556...54,573,240
Ensembl chr10:54,566,873...54,578,709
|
|
G |
Pmch |
pro-melanin-concentrating hormone |
|
IEP ISO |
associated with Hyperphagia;protein:increased expression:hypothalamus CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12355323 PMID:15363890 PMID:12453827 |
RGD:1624360, RGD:1642486 |
NCBI chr 7:22,511,934...22,513,250
Ensembl chr 7:22,511,934...22,513,250
|
|
G |
Pnlip |
pancreatic lipase |
susceptibility |
IAGP |
|
RGD |
PMID:15883013 |
RGD:1358859 |
NCBI chr 1:257,774,012...257,811,656
Ensembl chr 1:257,798,581...257,811,654
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
|
IEP |
|
RGD |
PMID:11431482 |
RGD:14985224 |
NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
|
|
G |
Pogz |
pogo transposable element derived with ZNF domain |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr 2:182,394,269...182,440,711
Ensembl chr 2:182,380,768...182,440,707
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO ISS IAGP IEP IDA |
DNA:mutations:multiple (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, early-onset, susceptibility to OMIM:601665 ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity disorder DNA:deletions:exons protein:decreased processing:arcuate nucleus of hypothalamus DNA:hypermethylation:promoter |
CTD ClinVar MouseDO OMIM RGD |
PMID:8302318 PMID:9620771 PMID:9768693 PMID:10193875 PMID:11941477 PMID:12165561 PMID:14557433 PMID:16289378 PMID:16459314 PMID:18091355 PMID:18697863 PMID:19153526 PMID:19221669 PMID:20349035 PMID:23293326 PMID:23649472 PMID:25741868 PMID:27906547 PMID:28492532 PMID:29970488 PMID:35574020 PMID:15189116 PMID:35343586 PMID:23640886 PMID:23958347 More...
|
RGD:1357925, RGD:406192936, RGD:407574730, RGD:407580525 |
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Pon2 |
paraoxonase 2 |
|
IEP |
protein:increased expression:white adipose tissue |
RGD |
PMID:21365757 |
RGD:8661255 |
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism mRNA, protein:decreased expression:left ventricle myocardium (rat) |
CTD RGD |
PMID:11089532 PMID:30738174 PMID:33310031 |
RGD:329955450 |
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16168052 PMID:20176998 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
susceptibility treatment |
IEP ISO |
mRNA:increased expression:adipose tissue DNA:point mutation:exon:P115Q DNA:polymorphism mRNA:decreased expression:retroperitoneal fat pad CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity due to SIM1 deficiency ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity disorder |
OMIM CTD ClinVar RGD |
PMID:9467001 PMID:9792554 PMID:10381354 PMID:10523018 PMID:10622252 PMID:10690291 PMID:10851250 PMID:11089532 PMID:14569127 PMID:14616762 PMID:14671186 PMID:15254591 PMID:22461176 PMID:25157153 PMID:25741868 PMID:28242765 PMID:28492532 PMID:18457007 PMID:9753710 PMID:18683148 PMID:18427128 PMID:15118671 PMID:30298849 More...
|
RGD:2301884, RGD:1601443, RGD:2301847, RGD:2301859, RGD:1331525, RGD:401960083 |
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
treatment |
IDA ISO IEP |
mRNA:increased expression:retroperitoneal fat pad (rat) mRNA:decreased expression:left ventricle myocardium (rat) |
RGD |
PMID:23256146 PMID:23180161 PMID:22401878 PMID:33310031 |
RGD:7241848, RGD:7242011, RGD:7242183, RGD:329955450 |
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppargc1b |
PPARG coactivator 1 beta |
resistance |
ISO |
DNA:polymorphism: :p.A203P CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Obesity, variation in |
CTD ClinVar RGD |
PMID:15863669 PMID:30738174 PMID:15863669 |
RGD:1642501 |
NCBI chr18:54,758,891...54,861,103
Ensembl chr18:54,758,902...54,861,194
|
|
G |
Ppia |
peptidylprolyl isomerase A |
|
ISO |
mRNA:increased expression:blood (human) |
RGD |
PMID:32496587 |
RGD:150383342 |
NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601
|
|
G |
Ppm1l |
protein phosphatase, Mg2+/Mn2+ dependent, 1L |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18344982 |
|
NCBI chr 2:153,566,653...153,839,434
Ensembl chr 2:153,566,653...153,839,434
|
|
G |
Prg2 |
proteoglycan 2, pro eosinophil major basic protein |
|
ISO |
mRNA:decreased expression:placenta (human) |
RGD |
PMID:28125591 |
RGD:40902990 |
NCBI chr 3:70,062,535...70,066,102
Ensembl chr 3:70,062,535...70,066,101
|
|
G |
Prkar1a |
protein kinase cAMP-dependent type I regulatory subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29367455 |
|
NCBI chr10:94,621,042...94,639,534
Ensembl chr10:94,620,039...94,639,041
|
|
G |
Prkar2b |
protein kinase cAMP-dependent type II regulatory subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20975297 |
|
NCBI chr 6:48,563,659...48,653,933
Ensembl chr 6:48,563,662...48,653,933
|
|
G |
Prkcb |
protein kinase C, beta |
|
IEP |
mRNA, protein:increased expression:mononuclear cell |
RGD |
PMID:17180352 |
RGD:1625512 |
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Prkcd |
protein kinase C, delta |
|
IEP |
protein:decreased expression:heart ventricle |
RGD |
PMID:11478406 |
RGD:1642533 |
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
|
|
G |
Prkch |
protein kinase C, eta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23563609 |
|
NCBI chr 6:92,292,000...92,490,663
Ensembl chr 6:92,292,000...92,490,654
|
|
G |
Prkci |
protein kinase C, iota |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr 2:112,321,919...112,382,305
Ensembl chr 2:112,321,929...112,382,352
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
|
IEP |
protein:increased expression:kidney, glomerulus |
RGD |
PMID:23454089 |
RGD:7777114 |
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Prl |
prolactin |
|
ISO |
|
RGD |
PMID:8388614 |
RGD:1642559 |
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Prlh |
prolactin releasing hormone |
|
IDA ISS |
OMIM:601665 |
MouseDO RGD |
PMID:15854142 |
RGD:1641829 |
NCBI chr 9:91,543,128...91,549,022
Ensembl chr 9:91,547,901...91,548,818
|
|
G |
Prlhr |
prolactin releasing hormone receptor |
|
IAGP |
|
RGD |
PMID:15854142 |
RGD:1641829 |
NCBI chr 1:259,606,704...259,608,391
Ensembl chr 1:259,606,704...259,608,391
|
|
G |
Prmt7 |
protein arginine methyltransferase 7 |
|
ISO |
ClinVar Annotator: match by term: Obesity disorder |
ClinVar |
PMID:25741868 PMID:26437029 PMID:27718516 PMID:28492532 PMID:28902392 |
|
NCBI chr19:34,110,724...34,161,531
Ensembl chr19:34,110,747...34,162,577
|
|
G |
Prox1 |
prospero homeobox 1 |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr13:101,669,184...101,719,804
Ensembl chr13:101,669,184...101,711,183
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21156398 PMID:21978752 |
RGD:5508307 |
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10744717 PMID:20075852 |
|
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
|
|
G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
|
IEP ISO |
protein:increased expression:skeletal muscle:increased 42% in insulin-resistant obese (fa/fa) and 50% in diabetic (ZDF/Drt-fa/fa) Zucker rats (P<0.05) |
RGD |
PMID:7666792 PMID:9218523 PMID:7769120 |
RGD:1642732, RGD:1642733, RGD:1642727 |
NCBI chr 5:131,741,959...131,824,000
Ensembl chr 5:131,742,754...131,810,023
|
|
G |
Pyy |
peptide YY |
|
ISO |
ClinVar Annotator: match by term: Obesity CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:10898754 PMID:11825645 PMID:16368708 |
|
NCBI chr10:87,061,155...87,062,278
Ensembl chr10:87,061,161...87,061,815
|
|
G |
Rab21 |
RAB21, member RAS oncogene family |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr 7:50,904,050...50,928,890
Ensembl chr 7:50,904,057...50,928,839
|
|
G |
Rai1 |
retinoic acid induced 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15459175 PMID:19116176 |
|
NCBI chr10:44,913,231...45,008,232
Ensembl chr10:44,947,909...45,008,232
|
|
G |
Rapgef3 |
Rap guanine nucleotide exchange factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr 7:128,875,772...128,898,203
Ensembl chr 7:128,875,773...128,898,521
|
|
G |
Rarres2 |
retinoic acid receptor responder 2 |
|
IEP |
protein:increased expression:serum: |
RGD |
PMID:31284705 PMID:30873215 |
RGD:15036824, RGD:15036825 |
NCBI chr 4:77,522,549...77,525,733
Ensembl chr 4:77,522,535...77,525,556
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
mRNA:decreased expression:adipose tissue |
RGD |
PMID:23315497 |
RGD:8547988 |
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbp4 |
retinol binding protein 4 |
disease_progression ameliorates |
IEP ISO |
mRNA, protein:decreased expression:adipose tissue, serum protein:increased expression:blood serum (human) |
RGD |
PMID:18401839 PMID:17292720 PMID:21585349 |
RGD:2302016, RGD:329845862, RGD:329853312 |
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
|
RGD |
PMID:18356846 |
RGD:2298856 |
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ren |
renin |
|
ISO |
mRNA:increased expression:abdomen, subcutaneous adipose tissue, mesenchymal stem cell (human) |
RGD |
PMID:22648117 |
RGD:6784503 |
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Retn |
resistin |
|
ISO |
mRNA, protein:increased expression:subcutaneous adipose tissue, serum DNA:SNP:promoter:-420G>C (rs1862513) (human) |
RGD |
PMID:22816026 PMID:17598818 PMID:11201732 |
RGD:7207072, RGD:7207155, RGD:7207158 |
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
|
|
G |
Rhoa |
ras homolog family member A |
|
IEP |
protein:increased expression:membrane, aorta, skeletal muscle |
RGD |
PMID:16267124 |
RGD:2298881 |
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
|
IEP |
protein:increased phosphorylation:skeletal muscle |
RGD |
PMID:15604215 |
RGD:1642978 |
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Rsrc2 |
arginine and serine rich coiled-coil 2 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr12:32,839,840...32,859,820
Ensembl chr12:32,839,809...32,859,799
|
|
G |
Rxra |
retinoid X receptor alpha |
susceptibility |
ISO |
|
RGD |
PMID:15936932 |
RGD:1643104 |
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Ryr1 |
ryanodine receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Obesity disorder |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
|
|
G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
|
|
G |
Scaper |
S-phase cyclin A-associated protein in the ER |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 PMID:30723319 |
|
NCBI chr 8:55,932,717...56,332,222
Ensembl chr 8:55,933,306...56,332,122
|
|
G |
Scd |
stearoyl-CoA desaturase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Sdc1 |
syndecan 1 |
|
ISO IEP |
mRNA:increased expression:liver |
RGD |
PMID:15189116 PMID:11522680 |
RGD:1357925, RGD:1643129 |
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
|
|
G |
Sdc3 |
syndecan 3 |
|
ISO |
ClinVar Annotator: match by term: Obesity, association with CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:17018662 |
|
NCBI chr 5:142,965,659...142,998,390
Ensembl chr 5:142,965,591...142,996,480
|
|
G |
Selp |
selectin P |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:altered localization:platelet |
RGD |
PMID:19228864 |
RGD:2312291 |
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
|
|
G |
Serpina12 |
serpin family A member 12 |
treatment |
IDA |
|
RGD |
PMID:16030142 |
RGD:1547845 |
NCBI chr 6:122,952,552...122,967,271
Ensembl chr 6:122,952,552...122,967,271
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23819014 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
ISO IEP |
protein:increased expression:serum (rat) |
RGD |
PMID:17491674 PMID:24424059 |
RGD:2312347, RGD:8633067 |
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Sftpa1 |
surfactant protein A1 |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:15136884 |
RGD:4143472 |
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
|
|
G |
Sftpb |
surfactant protein B |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:15136884 |
RGD:4143472 |
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
|
|
G |
Sh2b1 |
SH2B adaptor protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19079261 |
|
NCBI chr 1:181,048,622...181,057,036
Ensembl chr 1:181,048,623...181,056,579
|
|
G |
Sim1 |
SIM bHLH transcription factor 1 |
|
ISO ISS |
DNA:translocation OMIM:601665 ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity due to SIM1 deficiency | ClinVar Annotator: match by term: SIM1-related condition | ClinVar Annotator: match by term: UCP3-related condition ClinVar Annotator: match by term: NR0B2-related condition | ClinVar Annotator: match by term: Obesity due to SIM1 deficiency | ClinVar Annotator: match by term: SIM1-related condition |
MouseDO ClinVar RGD |
PMID:2152513 PMID:16924270 PMID:19401419 PMID:21512513 PMID:23778136 PMID:23778139 PMID:24097297 PMID:25234154 PMID:25741868 PMID:26795956 PMID:28492532 PMID:29216354 PMID:30991789 PMID:33434169 PMID:10587584 More...
|
RGD:1624165 |
NCBI chr20:53,827,601...53,907,219
Ensembl chr20:53,828,364...53,907,212
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
IMP IEP ISO |
protein:decreased expression:ovary CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:24184811 PMID:24773342 PMID:24135502 |
RGD:9585762, RGD:9586064 |
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Sirt3 |
sirtuin 3 |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23956348 PMID:21901160 |
RGD:9586047 |
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
|
|
G |
Sirt6 |
sirtuin 6 |
|
IEP |
protein:decreased expression:ovary |
RGD |
PMID:24135502 |
RGD:9586064 |
NCBI chr 7:8,082,312...8,087,776
Ensembl chr 7:8,082,364...8,098,914
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
disease_progression |
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:25612518 |
RGD:15045599 |
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
|
|
G |
Slc16a7 |
solute carrier family 16 member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 7:61,043,667...61,211,547
Ensembl chr 7:61,051,167...61,154,994
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20956498 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27401566 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a3 |
solute carrier family 22 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27401566 |
|
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
|
|
G |
Slc27a1 |
solute carrier family 27 member 1 |
susceptibility |
ISO IEP |
protein:increased expression:soleus muscle, protein:decreased expression:gastrocnemius muscle |
RGD |
PMID:16611988 PMID:15281014 |
RGD:1642790, RGD:1642794 |
NCBI chr16:18,278,984...18,300,173
Ensembl chr16:18,278,984...18,296,063
|
|
G |
Slc27a4 |
solute carrier family 27 member 4 |
|
ISO |
mRNA:increased expression:subcutaneous adipose tissue |
RGD |
PMID:15168018 |
RGD:1625638 |
NCBI chr 3:13,075,022...13,087,943
Ensembl chr 3:13,075,022...13,087,943
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
treatment |
ISO |
associated with Polycystic Ovary Syndrome |
RGD |
PMID:24842895 |
RGD:12879503 |
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc32a1 |
solute carrier family 32 member 1 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr 3:147,267,373...147,271,842
Ensembl chr 3:147,267,373...147,271,844
|
|
G |
Slc6a1 |
solute carrier family 6 member 1 |
|
ISO |
|
RGD |
PMID:11191352 |
RGD:1643191 |
NCBI chr 4:147,448,961...147,482,295
Ensembl chr 4:147,466,965...147,482,293
|
|
G |
Slc6a14 |
solute carrier family 6 member 14 |
susceptibility |
ISO |
DNA:SNPs |
RGD |
PMID:15331564 |
RGD:1625271 |
NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
no_association susceptibility |
ISO |
DNA:polymorphism |
RGD |
PMID:16674552 PMID:12490667 |
RGD:1625653, RGD:1625655 |
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
G |
Slc9a3 |
solute carrier family 9 member A3 |
|
IEP |
protein:decreased expression:kidney cortex |
RGD |
PMID:16757903 |
RGD:1625672 |
NCBI chr 1:29,124,633...29,167,912
Ensembl chr 1:29,124,674...29,167,417
|
|
G |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 8:20,167,717...20,258,975
Ensembl chr 8:20,167,717...20,258,975
|
|
G |
Snap25 |
synaptosome associated protein 25 |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
IEP |
mRNA, protein:increased expression:white fat |
RGD |
PMID:11027633 |
RGD:2298920 |
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
IEP ISO |
mRNA, protein:increased expression:white fat mRNA:decreased expression:subcutaneous adipose tissue mRNA:altered expression:skeletal muscle, subcutaneous adipose tissue DNA:SNP:utr (rs4969170) (human) |
RGD |
PMID:11027633 PMID:16920065 PMID:15331532 PMID:23900445 |
RGD:2298920, RGD:1625676, RGD:2313790, RGD:405650675 |
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24042701 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16317704 PMID:23956348 PMID:30738174 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
|
ISO |
DNA:SNP: :p.T228A (human) |
RGD |
PMID:11532984 |
RGD:1642744 |
NCBI chr 1:239,107,882...239,330,276
Ensembl chr 1:239,108,777...239,330,169
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
|
ISO |
mRNA:increased expression:adipose tissue |
RGD |
PMID:11294850 |
RGD:2300062 |
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
|
|
G |
Sqle |
squalene epoxidase |
|
ISO |
|
RGD |
PMID:15556298 |
RGD:1581399 |
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:20098742 |
RGD:4891511 |
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Obesity |
CTD ClinVar |
PMID:10900012 PMID:25741868 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
|
IEP |
protein:increased expression:fat cell, nucleus |
RGD |
PMID:9786926 |
RGD:2308843 |
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
IDA ISO |
protein:decreased phosphorylation:hypothalamus DNA:SNP:rs4796793 (human) |
RGD |
PMID:23397595 PMID:23900445 |
RGD:10411893, RGD:405650675 |
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
treatment |
IDA |
|
RGD |
PMID:20978234 |
RGD:5509594 |
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
IEP |
protein:decreased expression:gastrocnemius |
RGD |
PMID:16352671 |
RGD:1601389 |
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
|
|
G |
Sts |
steroid sulfatase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24497646 |
|
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
|
|
G |
Sucla2 |
succinate-CoA ligase ADP-forming subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr15:48,752,356...48,805,495
Ensembl chr15:48,752,312...48,805,138
|
|
G |
Suclg2 |
succinate-CoA ligase GDP-forming subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 4:128,067,031...128,337,146
Ensembl chr 4:128,067,033...128,337,170
|
|
G |
Szt2 |
SZT2 subunit of KICSTOR complex |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr 5:131,897,250...131,943,953
Ensembl chr 5:131,897,275...131,943,904
|
|
G |
Tbc1d1 |
TBC1 domain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16893906 PMID:18325908 PMID:18931681 |
|
NCBI chr14:43,936,820...44,135,133
Ensembl chr14:43,935,636...44,136,499
|
|
G |
Tbx3 |
T-box transcription factor 3 |
|
ISO |
ClinVar Annotator: match by term: Obesity disorder |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
|
ISO |
mRNA:increased expression:carotid artery |
RGD |
PMID:12409963 |
RGD:1601447 |
NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176
|
|
G |
Tf |
transferrin |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20882379 PMID:16267817 |
RGD:1601520 |
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tfam |
transcription factor A, mitochondrial |
treatment |
ISO IEP |
mRNA:decreased expression:left ventricle myocardium (rat) |
RGD |
PMID:21862610 PMID:33310031 |
RGD:5683906, RGD:329955450 |
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Tfrc |
transferrin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17062801 PMID:20882379 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
severity |
ISO IEP |
associated with hypertension;protein:increased expression:blood protein:increased expression:platelet protein:increased expression:adipose tissue |
RGD |
PMID:15944724 PMID:16477387 PMID:16253647 |
RGD:1601579, RGD:1601561, RGD:1601563 |
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Th |
tyrosine hydroxylase |
resistance |
ISO |
DNA:polymorphism:intron:g.1170_1173dupTCAT (human) |
RGD |
PMID:16251897 |
RGD:1601632 |
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thbd |
thrombomodulin |
severity |
ISO |
protein:increased expression:plasma |
RGD |
PMID:16651309 |
RGD:1601640 |
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
|
|
G |
Thbs1 |
thrombospondin 1 |
|
ISO |
mRNA,protein:increased expression:mononuclear cell, adipose tissue: |
RGD |
PMID:24086512 |
RGD:9681453 |
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:17512313 |
RGD:1642026 |
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
|
RGD |
PMID:18787058 |
RGD:2312681 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr4 |
toll-like receptor 4 |
susceptibility |
ISO IMP |
|
RGD |
PMID:19144836 PMID:17053832 PMID:19144836 |
RGD:2312510, RGD:1620653, RGD:2312510 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tmem18 |
transmembrane protein 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19079261 |
|
NCBI chr 6:47,206,845...47,214,294
Ensembl chr 6:47,206,845...47,214,294
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:9502777 PMID:11328671 PMID:20141834 PMID:29035695 PMID:24146106 PMID:28843383 More...
|
RGD:10450599, RGD:14975146 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:12935365 |
RGD:1624179 |
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
< |